Swiss Helvetia Fund, Inc.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number 811-05128
THE SWISS HELVETIA FUND, INC.
1270 Avenue of the Americas, Suite 400
New York, New York 10020
1-888-SWISS-00
Alexandre de Takacsy, President
Hottinger et Cie
3 Place des Bergues
C.P. 395
CH-1201 Geneva
Switzerland
Date of fiscal year end: December 31
Date of reporting period: January 1, 2010 June 30, 2010
Item 1. |
Reports to Stockholders. |
THE SWISS HELVETIA FUND, INC.
Directors and Officers
|
|
|
Samuel B. Witt III,
Esq.
Chairman (Non-executive) Jean-Marc
Boillat Director Richard A.
Brealey Director Alexandre de
Takacsy President
Director Claude W. Frey
Director Claus
Helbig1
Director R. Clark
Hooper2
Director Paul Hottinguer
Director Michael Kraynak,
Jr.1
Director Didier
PineauValencienne1,3
Director |
|
Stephen K. West,
Esq.1,4
Director Eric R. Gabus
Director Emeritus Baron
Hottinger Director Emeritus
Rudolf Millisits Chief Executive Officer
Chief Financial Officer
Philippe R. Comby, CFA, FRM
Vice President Edward J.
Veilleux Vice President
Secretary Glen Fougere
Assistant Secretary Patrick J. Keniston
Chief Compliance Officer |
1 Audit Committee Member
2 Audit Committee
Chair |
|
3 Governance/Nominating Committee
Chair 4 Pricing Committee
Chair |
Investment Advisor
Hottinger Capital Corp.
1270 Avenue of the
Americas, Suite 400
New York, NY 10020
(212) 332-7930
Administrator
Citi Fund Services Ohio,
Inc.
Custodian
Citibank, N.A.
Transfer Agent
American Stock
Transfer & Trust Company
59 Maiden Lane
Plaza Level
New York, NY 10038
Legal Counsel
Stroock & Stroock & Lavan LLP
Independent Registered Public Accounting Firm
Deloitte & Touche LLP
The Investment Advisor
The Swiss Helvetia Fund, Inc. (the Fund) is managed by Hottinger
Capital Corp., which belongs to the Hottinger Group.
The
Hottinger Group dates back to Banque Hottinguer, which was formed in Paris in 1786 and is one of Europes oldest private banking firms. The Hottinger Group has remained under the control of the Hottinger family through seven generations. It has
offices in Appenzell, the Bahamas, Basel, Brig, Geneva, London, Lugano, Luxembourg, New York, Paris, Sion, Toronto, Vienna, Zug and Zurich.
Executive Offices
The Swiss Helvetia
Fund, Inc.
1270 Avenue of the Americas, Suite 400
New York, New York 10020
1-888-SWISS-00
(1-888-794-7700)
(212) 332-2760
For inquiries and reports:
1-888-SWISS-00 (1-888-794-7700)
Fax:
(212) 332-7931
email: swz@swz.com
Website Address
www.swz.com
The Fund
The Fund is a non-diversified, closed-end investment company whose objective
is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. The Fund also may acquire and hold equity and equity-linked securities of non-Swiss companies in limited instances.
The Fund is listed on the New York Stock Exchange under the symbol
SWZ.
Net Asset Value is calculated daily by 6:15
P.M. (Eastern Time). The most recent calculation is available by calling 1-888-SWISS-00 or by accessing our Website. Net Asset Value is also published weekly in Barrons, the Monday edition of The Wall Street Journal and the
Sunday Edition of The New York Times.
1
THE SWISS HELVETIA FUND, INC.
Letter to Stockholders
Global Market Review
The overall positive sentiment during the first quarter was driven by resilient emerging market economies and positive macroeconomic data.
During the second quarter, however, momentum reached a turning point due to lackluster economic news, including rising concerns regarding the refinancing of European sovereign debt, the dramatic depreciation of the euro, the Gulf oil spill and
on-going financial reforms. In addition, the U.S. economic recovery appeared to be stalling, as could be seen in the most recent U.S. employment report, and Chinese authorities continued to implement tightening measures aimed at cooling its domestic
real estate market and domestic economic activity.
In the second quarter of 2010, in light of soaring volatility and the equity markets falling back to their August 2009 levels (the MSCI
World Index fell 13% in the second quarter and the Euro Stoxx 50 Index had a similar negative return), investors became risk averse. With a 12-month forward price earnings ratio of 9.9 times in June, the European market was trading at a historical
low. Earnings estimates were revised slightly downward by analysts in advance of the results. Looking at the possibility of further adjustments, market valuations remain supportive of further gains. A slower recovery for corporate sales and a much
lower inflation rate had a negative effect on pricing and margins. The valuation of the Swiss market already reflected those negative factors. As such, unless the Swiss economy enters a protracted period of deflation, the downside market risks are
limited.
During the second quarter of 2010,
global equity markets were negatively affected by disappointing macroeconomic data combined with a push to higher equity risk premiums. Market
sentiment continued to deteriorate even though risk premiums remained more attractive for equities relative to credit. The sovereign debt crisis in the Eurozone, compounded by pressure on the
euro and the lessening positive effect of stimulus programs, accelerated the spill-over effect for the global economy. In the Eurozone, 5-year credit-default swaps (CDS) for Ireland and Spain were trading very close to their highest levels of 2010
at the end of the first half of the year, despite the rescue package fashioned by the European Union. CDSs for Greece continued to indicate the strong possibility that a credit event could occur over the next few years. The European markets, led by
Greece, Italy and Spain, under performed Japan, Canada, the U.S. and the emerging markets.
At a microeconomic level, equities remained in good shape generating high free cash flow with a continued trend of increasing dividends
and share buybacks. Bottom-up analysis still indicated that second quarter earnings were likely to be sustained as many companies showed volume growth both on a quarterly and annual basis.
Swiss Economy Review
Swiss macroeconomic conditions, driven by a recovery in the export sector, resilient private consumption and a massive drop in inventories
saw sustained growth during the second quarter outpacing Europe. On the business front, the latest KOF Economic Barometer (a combined reading of 12 economic indicators) reflected the current healthy state of the Swiss business sector and indicated
further acceleration of Swiss Gross Domestic Product (GDP). Another positive development was the strong expansion of the monetary aggregate, M3, with a yearly growth rate above 7%, coupled with rising domestic bank credits of 4% on a year-over-year
basis.
2
THE SWISS HELVETIA FUND, INC.
Letter to Stockholders
(continued)
Currency
At its most recent monetary policy meeting, the Swiss National Bank (SNB) kept its target range for the three-month Libor rate unchanged
at 0.00%-0.75%. The SNBs comments on the Swiss economy were relatively upbeat. With improved economic conditions, as contrasted with deterioration in the countries on the periphery of the European Monetary Union, the SNB reversed course and
substantially reduced its efforts to stop the appreciation of the Swiss franc, which contributed to a massive increase in foreign currency reserves. As soon as the SNB started to stay on the side line in the currency market, the Swiss franc resumed
its upward trend against the euro and has reversed almost all of its loss against the U.S. dollar for the year. The outlook for the Swiss franc remains strong, given Switzerlands good fiscal position and the strength of its domestic economy
relative to its European peers.
Funds
Performance Review
During the second quarter, the energy, basic resources and banking sectors were the most negatively
affected sectors of the global indices. Tax increases in Germany raised concerns about the defensive nature of the utility sector. The Swiss Performance Index (SPI) also was negatively affected by the poor returns of banks, insurance companies and
the technology sector. Mid-size companies performed better in the downturn than blue chip companies, as indicated by the performance of the Swiss Small and Mid Cap Index (SMIM) (-7.4% versus -10.8% for the Swiss Market Index (SMI)).
The food sector was resilient (mainly due to the performance
of Nestle, which represents 95% of the sector), whereas pharmaceuticals, considered a defensive investment, had a negative return for the quarter. Transocean, newly-listed in Switzerland and added to the SPI on April 20th,
had a negative effect on the energy sector. Transocean shares ended the quarter with a return of -42% due to collapse of the Deepwater Horizon drilling platform in the Gulf of Mexico, which was
owned by the company and operated by British Petroleum. Because the Fund did not own this stock for most of the first half of the year, the Funds energy holdings outperformed the SPI during this period. Toward the end of June, however, the
Fund started to build a small position in Transocean as value started to emerge despite the negative effect of the platform explosion and resulting oil spill on business volumes. In Managements view, the companys share price already has
been discounted to account for substantial costs associated with the companys potential liabilities.
Fund management became more cautious on UBS and Credit Suisse during the second quarter. Their investment banking divisions will require
either higher returns for investors or more capital to absorb increased volatility, while their wealth management divisions continued to experience uncertainties due to an outflow of money resulting from the effect of various tax amnesties and
pressure from the automatic data exchange requested by European governments. Furthermore, despite increased expectations and the Swiss Parliaments June 17th approval of the deal between the Swiss Government and the U.S. Department of
Justice concerning UBS client data exchange, investor sentiment turned negative and UBS continued to remain under pressure. The Funds underweight position in the banking sector made a positive contribution to its relative performance against
the SPI.
Another positive contributor to the
Funds relative performance to the SPI was the consumer discretionary segment of the goods and services sector, which benefited from demand from emerging markets. In particular, watch industry
3
THE SWISS HELVETIA FUND, INC.
Letter to Stockholders
(continued)
exports grew at a double digit rate, benefiting Swatch and Richemont.
The Fund entered the second quarter with a relatively defensive position despite remaining underweight in pharmaceuticals. Management
further reduced the Funds exposure to cyclical industrial sectors and to the utility sector during the quarter and remained out of deflationary industries, such as telecom, preferring companies with pricing power. The Funds sizable cash
position during a short period of time was created by portfolio repositioning and was tactical. Successful sector allocation and stock selection resulted in the Funds outperformance against the SPI of 2.15% in the second quarter and cumulative
relative performance against the SPI of 1.57% for the first half of 2010.
Sector Review and Corporate News
Food
At its investor
seminar, Nestlé reiterated its 2010 targets but acknowledged challenges arising from the European economic climate. The company also confirmed the increasing importance of emerging markets, which are expected to represent nearly half of its
total sales in the next ten years. By mid-June, the company had completed 40% of its 25 billion Swiss franc share buyback program, which was initiated in August 2007.
Industrials
Earlier in the year, ABB reported mixed results for its power business and improved results for its industrial business. Its margins took
a hit as its backlog in highly profitable businesses was consumed and new sales were generated from lower priced orders.
In May, ABB agreed to acquire Ventyx, a leading software provider to global energy, utility and communications companies, for more than
$1 billion from Vista Equity Partners in an effort to increase its position as a provider of software solutions for managing energy networks. The acquisition reflects ABBs efforts to
broaden its portfolio companies and invest some of its cash position. The relatively hefty price paid for Ventyx (16 times earnings before interest, taxes, depreciation and amortization) is explained by the breadth of the Ventyx offerings and its
geographical fit with ABB. It also shows the strategic importance of ABB being part of the buildup of the smart grid. This upgraded electricity network should allow for a reduction of the energy consumption and an increase in the
reliability and security of the transmission and distribution of power. The new grid also should be better able to handle the increasing portion of electricity production coming from renewable sources.
Sulzer, a machinery and equipment manufacturer, benefited
from the economic recovery in the first quarter of 2010. Orders for large projects in the refining business boosted already strong activity in two of Sulzers main divisions.
With the proposed acquisition of Dowding & Mills, an
electrical and mechanical services company, for approximately 220 million Swiss francs ($210 million), Sulzer is expanding its turbo-service business by adding services for motors and generators. Dowding & Mills would add approximately
210 million Swiss francs ($200 million) in sales to Sulzer turbo-service division, almost doubling its size. This acquisition would reinforce Sulzers leading position as an independent service provider and reduce companys overall
business volatility.
Holcim, one of the
worlds largest cement producers, had a difficult year in 2009, particularly in Europe and the United States, which was partially offset by resilient volumes and pricing in the emerging markets, the source of 55% of its sales.
4
THE SWISS HELVETIA FUND, INC.
Letter to Stockholders
(continued)
The construction cycle is longer than the industrial cycle, as there is no inventory to
rebuild in anticipation of an economic recovery. Activity in Holcims sector is expected to remain sluggish in the developed markets following the second quarter economic results, but the companys exposure to European public spending that
could be adversely affected by austerity measures is low. Even though its last attempt to increase prices in the U.S. did not stick, higher energy and raw material costs should be shared with Holcims customers, at least with regard to
increased costs that Holcim cannot absorb by the lower cost structure it implemented during the last financial crisis.
In the same sector, companies such as Sika, the worlds second largest supplier of cement admixtures and its largest supplier of flat
roofing, benefited from trends in energy and water conservation. During the second quarter, Sika made two acquisitions in the waterproofing business. It purchased a majority stake in Japans Dyflex HD and also purchased a stake in Greenstreak,
a U.S. company. Sikas ability to capture business in repair and refurbishment, places it in a defensive position by giving it less exposure to new construction. The company is representative of a sizable number of Swiss mid-sized industrial
companies that have international exposure and are market share leaders in a global niche market.
Energy
Transocean and
Petroplus, a refiner, comprise the entire energy sector of the Swiss market. However, several manufacturing companies are linked to the performance of the energy sector through their exposure to energy capital expenditures in upstream and downstream
segments. These companies include Sulzer and Burckhardt Compression. ABB, by comparison, is more linked to capital expenditures in the utilities sector.
Since the explosion of the Deepwater Horizon platform, Transoceans market
capitalization has been cut in half. While Transoceans problems are very specific, the fundamentals for oil prices are strong. Spare oil production capacity is barely enough to satisfy a 4% increase in global consumption. Growth in emerging
market consumption, which accounts for 50% of global oil consumption, should be between 3% and 4% this year. The so-called conventional crude production has been flat since the middle of the decade with most discoveries occurring in
non-conventional production (50% of them are deep off-shore). The Gulf oil spill is an additional negative factor for non-OPEC supply, slowing down exploration and significantly increasing the cost of conducting business. Subsidies and price
controls by emerging market governments, combined with a loss of margins for national corporations, will contribute to the low price elasticity of demand as long as industrialization proceeds.
Financials
Central banks have been committed to providing significant liquidity, and even unlimited (in the case of the European Central Bank (ECB))
to banks. However, increases in banking regulation led to a downgrading of the financial sector in the second quarter, reflecting the challenges facing this sector. As a result, financial stocks were impacted by a dramatic sell-off, especially given
the continued negative Eurozone sovereign situation and the widening of Libor spreads, increasing the cost of short-term refinancing for banks.
During the last quarter, investors focused on the implications of a double dip recession, capital and liquidity regulations, taxation
changes and, especially for the Swiss banks, the too big to fail debate. Some concerns with both short and long-term funding risks were associated with
5
THE SWISS HELVETIA FUND, INC.
Letter to Stockholders
(continued)
European banks pushing up the spread between the three month interbank lending rates and the overnight lending rates in both the euro and the U.S. dollar markets.
The U.S. Congress recently approved a financial reform bill
that will, in part, limit proprietary trading by banks and increase substantially the regulation of the derivatives market. The Volcker rule, which prohibits banks from using their own capital to make speculative bets, was included in
the bill. However, the Democrats agreed to allow financial institutions to make limited investments in hedge funds and private equity funds up to 3% of their Tier 1 capital in such vehicles.
Within this new regulatory framework, large banks continued
to be a high risk and very speculative sector in the second quarter. Banks were negatively affected by downgrades of estimates coming on the back of the correction in the equity markets, which reduced asset-based fees and transaction levels in their
private banking and asset management businesses. Moreover their investment banking operations were negatively affected by decreases in fixed income revenues as a result of subdued activity, especially in the credit markets. Therefore, the Fund
maintained a cautious stance towards banks with a meaningful underweight compared to the sector weight in the SPI. On a positive note, expectations for UBS rose after the first quarter resulted in positive fixed income trading results and lower net
new money outflows than expected.
From an
international perspective, even though UBS and Credit Suisse currently operate in a difficult environment, they remain among the best capitalized banks when considering the implementation of the Basel III requirements. Both banks are in a position
to comply with those
requirements much faster than their peers, and without any significant capital requirement. Moreover, on a more positive note, some foreign clients increased the funds they had on deposit with
Swiss private banks with tax-declared money.
The
Fund added a position in Sarasin, a small private bank, based on its modest risk exposure to the banking secrecy developments compared to its peers. Sarasin remains well positioned to be a relative winner among Swiss private banks and outperformed
the SPI during the second quarter.
Real Estate
Stock prices of listed real estate companies, which are classified under financial services in the SPI, exhibited much less
volatility than the rest of the market during the first half of the year. High dividend yields contributed to the stability of share prices, as did the strength in the sectors activity on the back of a strong domestic economy, moderate supply
and sustained immigration. The average vacancy rate of the companies in the Funds portfolio has been relatively stable, with 6.5% being the highest for a single company in 2009.
Listed companies continue to lead consolidation within the
sector, as Swiss Prime Site more than doubled the value of its portfolio with the acquisition of Jelmolis real estate portfolio last year. Mobimo merged last year with LO Holding, increasing the size of its original portfolio by close to 30%.
In June, Mobimo launched a 155 million Swiss franc ($145 million) convertible bond issue to raise capital for future investments. The property portfolio for these companies is expanding at a relatively slow pace, however, due to the impact of
capital gains taxes and a lack of supply.
6
THE SWISS HELVETIA FUND, INC.
Letter to Stockholders
(continued)
Healthcare and Chemical
Austerity plans announced by several European governments will force a number of healthcare companies to react to lower public budgets and
to adjust their activities in certain countries. The industry lobby should continue to support premium prices for innovative medicines, pointing to the economic impact of a reduction in hospitalization that can be achieved with the new treatments.
In some specific cases, longer treatment also provides more clinical benefits, which improve the value for money. Despite the inevitable cost containment in a number of developed countries, Europe should remain a profitable area for the
pharmaceutical companies as the aging population and the growing incidence of cardiovascular, neuro- degenerative and metabolic disorders are driving the demand for innovative treatments in developed countries.
Investors interest in pharmaceuticals continues to be
low despite the attractive valuation of the sector (12 times on a forward price earnings basis). Before the release of second quarter figures, some analysts have modestly lowered their sales forecasts and earnings per share expectations. No major
surprises, however, are expected in company financial figures. The financial markets are expected to continue to assess the industrys capacity to create value through the development of new medicines and its management of the life cycle of
existing products. In that sense, Novartis has rejuvenated its product pipeline with several new drugs with blockbuster potential. In addition to its expected finalization of a transaction that will provide it with a 77% majority ownership in Alcon
by year end, the markets approval of Gilenia for multiple sclerosis (following the positive recommendation of an FDA advisory committee in June) will be among the most important new developments for Novartis. The companys share price
will be sensitive to any news related to Gilenias approval in the
coming months. The current valuation level of the companys stock does not reflect the full upside potential and the stock remains under-owned among asset managers. The Fund has overweighted
Novartis compared to Roche, whose performance continued to suffer from negative news of delays in drug approvals (Taspoglutide for diabetes) and uncertainties about Avastins potential to treat breast cancer. In the long term, Roche should
continue to benefit from its dominant cancer franchise and from its leadership in diagnostics.
The Fund had no exposure to medical technology in the quarter, and has reduced its exposure to biotech by eliminating its position in
Actelion at a profit.
The outlook of the chemical
sector has improved in 2010, despite rising prices for raw materials and a strong Swiss currency. Cost cutting measures also helped comparisons to the sectors 2009 results. Specialty chemical companies saw increased volumes early in the year
that could continue during the second half of the year. The companies management, however, remain particularly cautious with respect to European economic developments.
The crop protection industry, including Syngenta, was
penalized by Monsantos aggressive pricing strategy in the glyphosate (a non-selective herbicide) business. The commoditized agro-chemical business should continue to experience pricing pressure. No structural change, however, to pricing levels
for glyphosate is expected. Although long term fundamentals for fertilizers remain intact, the industry is expecting to experience some volatility.
Private Equity and Other Illiquid Investments
During the first half of the year, the Fund did not invest in any new direct or indirect private
7
THE SWISS HELVETIA FUND, INC.
Letter to Stockholders
(continued)
equity holdings. The Fund, however, did invest additional assets in Zurmont Madison and Aravis Biotech II, both private equity funds, as a result of capital calls made in accordance with the
terms of the Funds initial limited partnership agreements. The Funds total investments, including unfunded
commitments, in these two limited partnerships represent approximately 4% of the Funds total assets as of June 30, 2010. In addition, the Fund continues to have three illiquid direct
private equity holdings (Synosia Therapeutics AG, Kuros Biosurgery AG and NovImmune AG).
8
THE SWISS HELVETIA FUND, INC.
Letter to Stockholders
(continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Peer Group/Indices Performance Comparison in Swiss
Francs1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total return YTD
as of 6/30/10
|
|
Total return as of year ended
December 31
|
|
Cumulative Performance 12/31/96-
6/30/10
|
|
|
|
2009
|
|
2008
|
|
2007
|
|
2006
|
|
2005
|
|
2004
|
|
2003
|
|
2002
|
|
2001
|
|
2000
|
|
1999
|
|
1998
|
|
1997
|
|
Swiss Helvetia Fund |
|
-2.31% |
|
-5.05% |
|
-28.19% |
|
-2.67% |
|
20.56% |
|
33.20% |
|
7.75% |
|
22.54% |
|
-20.40% |
|
-22.91% |
|
14.06% |
|
14.70% |
|
15.57% |
|
53.99% |
|
96.39% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Swiss Performance Index (SPI) |
|
-3.88% |
|
23.18% |
|
-34.05% |
|
-0.05% |
|
20.67% |
|
35.61% |
|
6.89% |
|
22.06% |
|
-25.95% |
|
-22.03% |
|
11.91% |
|
11.69% |
|
15.36% |
|
55.19% |
|
115.28% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Swiss Market Index (SMI) |
|
-6.38% |
|
18.27% |
|
-34.77% |
|
-3.43% |
|
15.85% |
|
33.21% |
|
3.74% |
|
18.51% |
|
-27.84% |
|
-21.11% |
|
7.47% |
|
5.71% |
|
14.28% |
|
58.93% |
|
55.44% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
iShares Switzlerland2 |
|
-4.81% |
|
18.55% |
|
-31.59% |
|
-0.97% |
|
20.02% |
|
32.45% |
|
6.34% |
|
19.14% |
|
-26.23% |
|
-23.12% |
|
7.75% |
|
12.22% |
|
11.74% |
|
47.79% |
|
74.37% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CS EF (CH) Swiss Blue Chips3,7 |
|
-4.39% |
|
19.98% |
|
-35.72% |
|
-1.66% |
|
18.78% |
|
32.27% |
|
2.75% |
|
18.13% |
|
-28.75% |
|
-22.12% |
|
10.97% |
|
7.57% |
|
14.21% |
|
59.90% |
|
67.27% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UBS (CH) Equity Fund4,7 |
|
-4.29% |
|
22.44% |
|
-33.76% |
|
-2.55% |
|
18.98% |
|
33.50% |
|
5.00% |
|
18.14% |
|
-26.02% |
|
-22.04% |
|
7.42% |
|
6.43% |
|
12.75% |
|
55.94% |
|
72.80% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pictet (CH) Swiss Equities5,7 |
|
-4.11% |
|
27.00% |
|
-36.50% |
|
1.94% |
|
19.37% |
|
37.06% |
|
7.05% |
|
20.10% |
|
-27.93% |
|
-22.35% |
|
7.34% |
|
9.38% |
|
11.05% |
|
55.65% |
|
88.32% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Saraswiss (Bank Sarasin)6,7 |
|
-2.75% |
|
18.62% |
|
-34.87% |
|
-2.86% |
|
18.69% |
|
33.05% |
|
2.93% |
|
19.64% |
|
-28.51% |
|
-24.45% |
|
9.72% |
|
7.10% |
|
14.41% |
|
53.57% |
|
58.27% |
Sources: Bloomberg, management companies
websites and Citi Fund Services Ohio, Inc.
1 Performance of funds is based
on changes in each funds NAV over a specified period. In each case total return is calculated assuming reinvestment of all distributions. Funds listed, other than iShares MSCI Switzerland, are not registered with the Securities and Exchange
Commission. Performance and descriptive information about the funds are derived from their published investor reports and websites, which are subject to change.
2 Shares of iShares MSCI
Switzerland are traded on the NYSE Arca and seeks to provide investment results that correspond to the performance of the Swiss market, as measured by the MSCI Switzerland Index. These stocks represent Switzerlands largest and most established
public companies, accounting for approximately 85% of the market capitalization of all Switzerlands publicly traded stocks. Performance of shares of iShares MSCI Switzerland is calculated based upon the closing prices of the period indicated
using the Swiss franc/U.S. dollar exchange rate as of noon each such date, as reported by Bloomberg. Such exchange rates were as follows: 12/31/97 = 1.46, 12/31/98 = 1.38, 12/31/99 = 1.60, 12/31/00 = 1.61, 12/31/01 = 1.67,
12/31/02 = 1.39, 12/31/03 = 1.24, 12/31/04 = 1.14 12/31/05 = 1.32, 12/31/06 = 1.22, 12/31/07 = 1.13, 12/31/08 = 1.06, 12/31/09 = 1.034, 6/30/10 = 1.078
3 This fund gives investors
access to the Swiss equity market. It has a broadly-diversified portfolio geared to the long-term value growth, with a preference to large cap stocks. Stock selection is based on criteria such as company valuation, business climate, market
positioning and management quality.
4 This fund invests primarily in
major Swiss companies. Quality criteria used for determining relative weightings of companies include: strategic orientation, strength of market position, quality of management, soundness of earnings, growth potential and potential for improving
shareholder value. The investment objective seeks to provide results that are aligned with the SPI performance.
5 This fund invests in shares of
companies listed in Switzerland and included in the SPI, mainly in blue chip stocks.
6 This fund invests in shares of
Swiss companies. It weights individual sectors relative to the SPI on the basis of their expected relative performance. It focuses on liquid blue-chip stocks.
7 These funds are not available
for U.S. residents or citizens.
Past performance is no guarantee of future results.
9
THE SWISS HELVETIA FUND, INC.
Letter to Stockholders
(continued)
Summary of Investment Themes
The Funds strategy, in part, relies on stock selection and a sector allocation process following investment themes that Management
believes should provide superior returns. As previously mentioned, growth in emerging markets and in consumer spending, especially with regard to global brands, is structural in nature and should continue to support the activities of Swiss export
companies.
In the energy sector, investments in
infrastructure are needed to keep up with increased demand from emerging markets. In addition, increased energy efficiency and energy conservation, combined with increased production from renewable sources, will be critical components to addressing
ongoing climate concerns.
As Management is again
concerned with an increasing risk of deflation, the Funds recent investments have been focused in companies with meaningful market positions in specific industries and niche markets, that can continue to shift their offerings to higher
value-added services and provide customers with systems or solutions rather than a single product. We believe that this type of company should be able to demonstrate pricing power.
Balance sheet quality is another important investment
criterion. Equity capital is usually under pressure in a deflationary environment where financing costs are on the rise.
Indices Performance
Comparison
|
|
|
|
|
Year to Date December 31, 2009 through June 30,
2010
|
Performance in Swiss Francs |
|
|
|
|
|
Swiss Performance Index (SPI) |
|
-3.88% |
|
|
|
Swiss Helvetia Fund |
|
|
|
|
|
Based on Net Asset Value |
|
-2.31% |
|
|
|
Change in U.S. Dollar vs. Swiss Franc |
|
4.31% |
|
|
|
Performance in U.S. Dollars |
|
|
|
|
|
Swiss Helvetia Fund Performance |
|
|
|
|
|
Based on Net Asset Value |
|
-6.35% |
|
|
|
Based on Market Price |
|
-8.18% |
|
|
|
S & P 500 Index |
|
-6.64% |
|
|
|
MSCI EAFE Index |
|
-13.23% |
|
|
|
Lipper European Fund Index (10 Largest) |
|
-13.82% |
|
|
|
Lipper European Fund Universe Average |
|
-14.58% |
Source: Citi Fund Services Ohio, Inc.
Outlook
Second quarter earnings releases could surprise investors on the upside as the effect of government austerity measures are not yet visible
in corporate results and the restoration of inventories is in full swingas demonstrated by freight forwarding companies. The benefits of operating leverage, with higher sales volume on lower fixed costs, also should be apparent for some
companies. On the other hand, cost inflation and negative currency trends remain as lingering concerns over the next few quarters.
10
THE SWISS HELVETIA FUND, INC.
Letter to Stockholders
(concluded)
From a macroeconomic perspective, the European rescue package and solidarity within the
Eurozone have greatly reduced systemic risk and extended the current period of accommodative monetary policy. However, negative sentiment and persistent uncertainties surrounding Eurozone sovereignty issues have led Eurozone economists to reduce
their forecasts for economic growth, revising expectations for an ECB rate hike from September 2010 to mid-2011. The ECB reduced its expectations for bank write-offs in 2010 by 38 billion euros and already has purchased government bonds with a value
of more than 50 billion euros. The euros depreciation against the dollar of more than 16% in the first half of 2010 will partially support European exports, mitigating the European economic slowdown.
For the time being, European austerity measures are primarily based on spending cuts rather
than tax increases, which historically have proven to be successful when coupled with accommodative monetary policy in a context of ultra-low interest rates.
Sincerely,
Alexandre de
Takacsy
President
Rudolf Millisits
Chief Executive Officer and Chief Financial Officer
11
THE SWISS HELVETIA FUND, INC.
Review of Operations
(Unaudited)
Trading activity for the six months ended June 30, 2010 involved changes in the following positions:
New Investments by the Fund
Bank
Sarasin & Cie AG
Burckhardt Compression Holding AG
Compagnie Financiere Richemont SA, Series A
Forbo Holding AG
Gategroup Holding AG
Kudelski SA
Meyer Burger Technology AG
Rieter Holding AG
Schweiter Technologies AG
Sulzer AG
Transocean, Ltd.
Additions to Existing Investments
ABB, Ltd.
Aravis Biotech II Limited Partnership
Credit Suisse Group
Dufry Group
Kuehne + Nagel International AG
Novartis AG
Swiss Re
Zurich Financial Services AG
Zurmont Madison Private Equity,
Limited Partnership
Securities Disposed of/Expired
Actelion, Ltd.
Adecco SA
Alpiq Holding, Ltd.
Credit Suisse Group Call Warrant Expiring 03/19/10
Electrizitaets-Gesellschaft Laufenburg AG
Julius Baer Holding AG
Call Warrant Expiring 06/18/10
Novartis AG Call Warrant Expiring 03/19/10
OC Oerlikon Corp. AG
Raetia Energie AG
SLI Swiss Leader Index Call Warrant Expiring 03/19/10
SMIM
Put Warrant Expiring 02/19/10
Swiss Re Call Warrant Expiring 03/19/10
UBS AG Call Warrant Expiring 03/19/10
UBS AG Call
Warrant Expiring 06/18/10
Reductions in Existing Investments
Addex Pharmaceuticals, Ltd.
Galenica AG
Holcim, Ltd.
Nestle SA
Roche Holding AG
Romande Energie Holding SA
SGS SA
Sika AG
Swatch Group AG
Syngenta AG
Temenos Group AG
12
THE SWISS HELVETIA FUND, INC.
|
|
|
|
|
Schedule of Investments
(Unaudited) |
|
June 30, 2010 |
|
|
|
|
|
|
|
|
|
No. of Shares |
|
Security |
|
Fair Value |
|
Percent of Net Assets |
|
Common Stocks 87.24% |
|
|
|
|
|
|
|
|
|
Banks 7.42% |
|
|
|
|
|
|
|
|
|
|
108,000 |
|
Bank Sarasin & Cie AG Registered Shares |
|
$ |
4,326,610 |
|
1.11 |
% |
|
|
Offers private banking, asset management, investment advisory, and institutional banking services. (Cost $3,988,696) |
|
|
|
|
|
|
|
|
|
|
434,000 |
|
Credit Suisse Group1 Registered Shares |
|
|
16,468,939 |
|
4.22 |
% |
|
|
A global diversified financial service company with significant activity in private banking, investment banking, asset management and insurance service. (Cost $18,678,431) |
|
|
|
|
|
|
|
|
|
|
610,000 |
|
UBS AG1,2 Registered Shares |
|
|
8,179,719 |
|
2.09 |
% |
|
|
A global diversified financial service company with significant activity in private banking, investment banking, and asset management. (Cost $6,276,207) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28,975,268 |
|
7.42 |
% |
|
|
|
Biotechnology 1.53% |
|
|
|
|
|
|
|
|
|
|
480,058 |
|
Addex Pharmaceuticals, Ltd.2,3
Registered Shares |
|
|
4,496,301 |
|
1.15 |
% |
|
|
Bio-pharmaceutical company that discovers and develops allosteric modulators for human health. Allosteric modulators are a different kind of orally available small molecule therapeutic
agent. (Cost $21,209,722) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No. of Shares |
|
Security |
|
Fair Value |
|
Percent of Net Assets |
|
|
|
|
|
|
|
|
Biotechnology (continued) |
|
|
|
|
|
|
|
|
|
|
3,029 |
|
NovImmune SA2,4,5,6 Common Shares |
|
$ |
1,486,901 |
|
0.38 |
% |
|
|
Discovers and develops therapeutic monoclonal antibodies (mAbs) to treat patients suffering from immune-related disorders. (Cost $1,551,109) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,983,202 |
|
1.53 |
% |
|
|
|
Chemicals 1.85% |
|
|
|
|
|
|
|
|
|
|
31,000 |
|
Syngenta AG Registered Shares |
|
|
7,204,154 |
|
1.85 |
% |
|
|
Produces herbicides, insecticides and fungicides, and seeds for field crops, vegetables, and flowers. (Cost $7,417,397) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,204,154 |
|
1.85 |
% |
|
|
|
Commercial Services 1.11% |
|
|
|
|
|
|
|
|
|
|
3,200 |
|
SGS SA
Registered
Shares |
|
|
4,338,480 |
|
1.11 |
% |
|
|
Provides industrial inspection, analysis, testing, and verification services worldwide. (Cost $4,144,258) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4,338,480 |
|
1.11 |
% |
|
|
|
Construction & Materials 2.67% |
|
|
|
|
|
|
|
|
|
|
1,141 |
|
Belimo Holding AG Registered Shares |
|
|
1,349,075 |
|
0.34 |
% |
|
|
World market leader in damper and volume control actuators for ventilation and air-conditioning equipment. (Cost $222,726) |
|
|
|
|
|
|
See Notes to Financial Statements.
13
THE SWISS HELVETIA FUND, INC.
|
|
|
|
|
Schedule of Investments (Unaudited)
(continued) |
|
June 30, 2010 |
|
|
|
|
|
|
|
|
|
No. of Shares |
|
Security |
|
Fair Value |
|
Percent of Net Assets |
|
Common Stocks (continued) |
|
|
|
|
|
|
Construction & Materials (continued) |
|
|
|
|
|
|
|
|
|
|
2,000 |
|
Forbo Holding AG Registered Shares |
|
$ |
851,301 |
|
0.22 |
% |
|
|
Produces floor coverings, adhesives, and belts for conveying and power transmission. (Cost $697,165) |
|
|
|
|
|
|
|
|
|
|
70,700 |
|
Holcim, Ltd. Registered Shares |
|
|
4,776,274 |
|
1.22 |
% |
|
|
Produces building materials. (Cost $3,960,128) |
|
|
|
|
|
|
|
|
|
|
1,944 |
|
Sika AG Bearer Shares |
|
|
3,461,288 |
|
0.89 |
% |
|
|
Leading producer of construction chemicals. (Cost $2,700,457) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,437,938 |
|
2.67 |
% |
|
|
Diversified Manufacturing Operation 2.04% |
|
|
|
|
|
|
|
18,000 |
|
Burckhardt Compression Holding AG Bearer Shares |
|
|
3,184,866 |
|
0.81 |
% |
|
|
Produces compressors for oil refining, the chemical and petrochemical industries, industrial gases, and gas transport and storage. (Cost $3,238,445) |
|
|
|
|
|
|
|
|
|
|
51,000 |
|
Sulzer AG Registered Shares |
|
|
4,790,930 |
|
1.23 |
% |
|
|
Manufactures and sells surface coatings, pumps, process engineering equipment, and fuel cells. (Cost $5,418,052) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,975,796 |
|
2.04 |
%
|
|
|
|
|
|
|
|
|
|
No. of Shares |
|
Security |
|
Fair Value |
|
Percent of Net Assets |
|
|
|
|
|
|
|
|
Food & Beverages 19.56% |
|
|
|
|
|
|
|
|
|
|
135 |
|
Lindt & Sprungli AG Registered Shares |
|
$ |
3,317,568 |
|
0.85 |
% |
|
|
Major manufacturer of premium Swiss chocolates. (Cost $471,625) |
|
|
|
|
|
|
|
|
|
|
1,509,000 |
|
Nestle SA1 Registered Shares |
|
|
73,046,599 |
|
18.71 |
% |
|
|
Largest food and beverage processing company in the world. (Cost $26,138,927) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
76,364,167 |
|
19.56 |
% |
|
|
|
Industrial Goods & Services 9.45% |
|
|
|
|
|
|
|
|
|
|
640,000 |
|
ABB, Ltd.1 Registered Shares |
|
|
11,258,682 |
|
2.89 |
% |
|
|
The holding company for ABB Group, which is one of the largest electrical engineering firms in the world. (Cost $13,571,947) |
|
|
|
|
|
|
|
|
|
|
110,000 |
|
Gategroup Holding AG2 Bearer Shares |
|
|
3,473,362 |
|
0.89 |
% |
|
|
Provides a wide range of global services for airlines, railroads and hotels. Specializes in catering and hospitality; provisioning and logistics; and onboard solutions to companies that
serve people on the move. (Cost $4,102,084) |
|
|
|
|
|
|
See Notes to Financial Statements.
14
THE SWISS HELVETIA FUND, INC.
|
|
|
|
|
Schedule of Investments (Unaudited)
(continued) |
|
June 30, 2010 |
|
|
|
|
|
|
|
|
|
No. of Shares |
|
Security |
|
Fair Value |
|
Percent of Net Assets |
|
Common Stocks (continued) |
|
|
|
|
|
|
Industrial Goods & Services (continued) |
|
|
|
|
|
|
|
|
|
|
6,440 |
|
Inficon Holding AG Registered Shares |
|
$ |
833,106 |
|
0.21 |
% |
|
|
Manufactures and markets vacuum instruments used to monitor and control production processes. Manufactures on-site chemical detection and monitoring systems. (Cost $581,616) |
|
|
|
|
|
|
|
|
|
|
54,744 |
|
Kuehne + Nagel International AG Registered Shares |
|
|
5,675,689 |
|
1.45 |
% |
|
|
Transports freight worldwide. (Cost $4,438,559) |
|
|
|
|
|
|
|
|
|
|
157,000 |
|
Meyer Burger Technology AG2 Bearer Shares |
|
|
3,909,167 |
|
1.00 |
% |
|
|
Manufactures industrial cutting equipment. Produces wire, band, ID, OD and diamond wire saws, and slurry reclamation equipment. (Cost $4,121,684) |
|
|
|
|
|
|
|
|
|
|
30,290 |
|
Rieter Holding AG1,2 Registered Shares |
|
|
7,724,533 |
|
1.98 |
% |
|
|
Manufactures spinning systems, chemical fibre systems and noise control products. The companys spinning and chemical fibre systems are used to process cotton and plastic and man-made
fibres. (Cost $8,510,182) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No. of Shares |
|
Security |
|
Fair Value |
|
Percent of Net Assets |
|
|
|
|
|
|
|
Industrial Goods & Services (continued) |
|
|
|
|
|
|
|
7,964 |
|
Schweiter Technologies AG Bearer Shares |
|
$ |
4,025,020 |
|
1.03 |
% |
|
|
Manufactures textile machinery used primarily in the production and treatment of yarn, thread and textile samples. Produces machines for the assembly and packaging of semiconductor
devices. (Cost $4,386,365) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
36,899,559 |
|
9.45 |
% |
|
|
|
Insurance 4.34% |
|
|
|
|
|
|
|
|
|
|
83,000 |
|
Swiss Re Registered Shares |
|
|
3,441,304 |
|
0.88 |
% |
|
|
Offers reinsurance and insurance linked financial market products. (Cost $3,929,257) |
|
|
|
|
|
|
|
|
|
|
60,800 |
|
Zurich Financial Services AG1 Registered Shares |
|
|
13,503,593 |
|
3.46 |
% |
|
|
Offers property, accident, health, automobile, liability, financial risk and life insurance and retirement products. (Cost $13,625,007) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16,944,897 |
|
4.34 |
% |
|
|
|
Medical Technology 0.65% |
|
|
|
|
|
|
|
|
|
|
168,000 |
|
Kuros Biosurgery AG4,5,6 Registered Shares |
|
|
2,523,856 |
|
0.65 |
% |
|
|
A biotechnology company dedicated to developing biomaterials and bioactive biomaterial combination products for indications in trauma, wound and spine. (Cost $2,516,639) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,523,856 |
|
0.65 |
% |
See Notes to Financial Statements.
15
THE SWISS HELVETIA FUND, INC.
|
|
|
|
|
Schedule of Investments (Unaudited)
(continued) |
|
June 30, 2010 |
|
|
|
|
|
|
|
|
|
No. of Shares |
|
Security |
|
Fair Value |
|
Percent of Net Assets |
|
Common Stocks (continued) |
|
|
|
|
|
|
|
|
|
Oil & Gas 0.93% |
|
|
|
|
|
|
|
|
|
|
76,000 |
|
Transocean, Ltd.2 Bearer Shares |
|
$ |
3,608,476 |
|
0.93 |
% |
|
|
Owns or operates mobile offshore drilling units, inland drilling barges, and other assets utilized in the support of offshore drilling activities worldwide. (Cost
$4,008,155) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,608,476 |
|
0.93 |
% |
|
|
|
Personal & Household Goods 2.24% |
|
|
|
|
|
|
|
|
|
|
30,800 |
|
Swatch Group AG1 Bearer Shares |
|
|
8,754,300 |
|
2.24 |
% |
|
|
Manufactures finished watches, movements and components. Produces components necessary to its eighteen watch brand companies. Also operates retail boutiques. (Cost
$7,845,546) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8,754,300 |
|
2.24 |
% |
|
|
|
Pharmaceuticals 21.98% |
|
|
|
|
|
|
|
|
|
|
1,114,700 |
|
Novartis AG1 Registered Shares |
|
|
54,373,089 |
|
13.93 |
% |
|
|
One of the leading manufacturers of branded and generic pharmaceutical products. Manufactures nutrition products. (Cost $31,771,769) |
|
|
|
|
|
|
|
|
|
|
227,200 |
|
Roche Holding AG1 Non-voting equity securities |
|
|
31,414,216 |
|
8.05 |
% |
|
|
Worldwide pharmaceutical company. (Cost $4,015,648) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
85,787,305 |
|
21.98 |
%
|
|
|
|
|
|
|
|
|
|
No. of Shares |
|
Security |
|
Fair Value |
|
Percent of Net Assets |
|
|
|
|
|
|
|
|
Real Estate & Infrastructure 4.00% |
|
|
|
|
|
|
|
|
|
|
31,000 |
|
Mobimo Holding AG2 Registered Shares |
|
$ |
5,404,553 |
|
1.39 |
% |
|
|
Builds and renovates residential real estate and invests in commercial real estate. (Cost $4,747,595) |
|
|
|
|
|
|
|
|
|
|
135,000 |
|
PSP Swiss Property AG1 Registered Shares |
|
|
8,093,615 |
|
2.07 |
% |
|
|
Owns and manages real estate, including a portfolio of office buildings in the financial and historic sections of the five largest Swiss cities. (Cost $7,526,003) |
|
|
|
|
|
|
|
|
|
|
35,000 |
|
Swiss Prime Site AG2 Registered Shares |
|
|
2,122,688 |
|
0.54 |
% |
|
|
Owns business and mixed-use business/residential buildings in commercial centers in Switzerland. (Cost $2,028,007) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,620,856 |
|
4.00 |
% |
|
|
|
Retailers 4.52% |
|
|
|
|
|
|
|
|
|
|
206,000 |
|
Compagnie Financiere Richemont SA,
Series A Bearer Shares |
|
|
7,249,687 |
|
1.86 |
% |
|
|
Manufactures and retails luxury goods. Produces jewelry, watches, leather goods, writing instruments, and mens and womens wear. (Cost $7,631,603) |
|
|
|
|
|
|
See Notes to Financial Statements.
16
THE SWISS HELVETIA FUND, INC.
|
|
|
|
|
Schedule of Investments (Unaudited)
(continued) |
|
June 30, 2010 |
|
|
|
|
|
|
|
|
|
No. of Shares |
|
Security |
|
Fair Value |
|
Percent of Net Assets |
|
Common Stocks (continued) |
|
|
|
|
|
|
|
|
|
Retailers (continued) |
|
|
|
|
|
|
|
|
|
|
83,000 |
|
Dufry Group2 Registered Shares |
|
$ |
6,265,313 |
|
1.60 |
% |
|
|
Operates duty-free shops in countries such as Tunisia, Italy, Mexico, France, Russia, the United Arab Emirates, Singapore, the Caribbean and the United States. (Cost $5,225,267)
|
|
|
|
|
|
|
|
|
|
|
10,600 |
|
Galenica AG Registered Shares |
|
|
4,118,700 |
|
1.06 |
% |
|
|
Manufactures and distributes prescription and over-the-counter drugs, toiletries and hygiene products. (Cost $3,051,975) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17,633,700 |
|
4.52 |
% |
|
|
|
Technology 2.34% |
|
|
|
|
|
|
|
|
|
|
202,900 |
|
Kudelski SA Bearer Shares |
|
|
5,522,432 |
|
1.41 |
% |
|
|
Designs and manufactures digital security products. (Cost $6,223,174) |
|
|
|
|
|
|
|
|
|
|
149,500 |
|
Temenos Group AG2 Registered Shares |
|
|
3,625,377 |
|
0.93 |
% |
|
|
Provides integrated software for the banking sector. (Cost $3,482,574) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,147,809 |
|
2.34 |
%
|
|
|
|
|
|
|
|
|
|
No. of Shares/ Units |
|
Security |
|
Fair Value |
|
Percent of Net Assets |
|
|
|
|
|
|
|
|
|
|
|
Utility Suppliers 0.61% |
|
|
|
|
|
|
|
|
|
|
1,544 |
|
Romande Energie Holding SA Registered Shares |
|
$ |
2,391,135 |
|
0.61 |
% |
|
|
Distributes electricity in the Canton of Vaud. Provides repair and other electrical services to its customers. (Cost $3,813,084) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,391,135 |
|
0.61 |
% |
|
|
|
|
|
|
Total Common Stocks (Cost $257,267,085) |
|
|
340,590,898 |
|
87.24 |
% |
|
|
|
Preferred Stocks 0.98% |
|
|
|
|
|
|
|
|
|
Biotechnology 0.98% |
|
|
|
|
|
|
|
|
|
|
3,162 |
|
NovImmune SA, Series B Preferred Shares4,5,6 |
|
|
|
|
|
|
|
|
Discovers and develops therapeutic monoclonal antibodies (mAbs) to treat patients suffering from immune-related disorders. (Cost $2,062,307) |
|
|
1,977,836 |
|
0.51 |
% |
|
|
|
|
133,200 |
|
Synosia Therapeutics Holding AG, Series B Preferred Shares4,5,6 |
|
|
|
|
|
|
|
|
Develops and intends to commercialize innovative products for unmet medical needs in psychiatry and neurology. (Cost $1,740,545) |
|
|
1,854,684 |
|
0.47 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Preferred Stocks (Cost $3,802,852) |
|
|
3,832,520 |
|
0.98 |
% |
See Notes to Financial Statements.
17
THE SWISS HELVETIA FUND, INC.
|
|
|
|
|
Schedule of Investments (Unaudited)
(continued) |
|
June 30, 2010 |
|
|
|
|
|
|
|
|
|
No. of Shares/ Units |
|
Security |
|
Fair Value |
|
Percent of Net Assets |
|
Convertible Corporate Bond 1.59% |
|
|
|
|
|
|
|
|
|
Industrial Goods & Services 1.59% |
|
|
|
|
|
|
|
|
|
|
6,500,000 |
|
Adecco Investment Bond 6.50%, 11/26/12 |
|
|
|
|
|
|
|
|
(Cost $6,387,196) |
|
$ |
6,208,560 |
|
1.59 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Convertible Corporate Bond (Cost $6,387,196) |
|
|
6,208,560 |
|
1.59 |
% |
|
|
Private Equity Limited Partnerships 1.86% |
|
|
|
|
|
|
|
|
|
Aravis Biotech Il - Limited Partnership2,4,5,6 (Cost $1,693,367) |
|
|
1,629,700 |
|
0.42 |
%
|
|
|
|
|
|
|
|
|
|
No. of Shares/ Units |
|
Security |
|
Fair Value |
|
Percent of Net Assets |
|
|
|
|
|
|
|
Private Equity Limited Partnerships (continued) |
|
|
|
|
|
|
|
|
|
Zurmont Madison Private Equity, Limited Partnership2,4,5,6 (Cost $8,020,652) |
|
$ |
5,635,711 |
|
1.44 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Private Equity Limited Partnerships (Cost $9,714,019) |
|
|
7,265,411 |
|
1.86 |
% |
|
|
|
|
|
|
Total Investments* (Cost $277,171,152) |
|
|
357,897,389 |
|
91.67 |
% |
|
|
|
|
|
|
Other Assets less Other Liabilities, net |
|
|
32,505,281 |
|
8.33 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Assets |
|
$ |
390,402,670 |
|
100.0 |
% |
|
|
|
|
|
|
|
|
|
1 |
|
One of the ten largest portfolio holdings. |
2 |
|
Non-income producing security. |
3 |
|
Affiliated Company. An affiliated company is a company in which the Fund has ownership of at least 5% of the companys outstanding voting securities.
Transactions during the year with companies which were affiliates are as follows: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name of Issuer
|
|
Shares Held as of 12/31/09
|
|
Value as of
12/31/09
|
|
Gross Additions
|
|
Gross Reductions
|
|
|
Income
|
|
Shares Held as of 6/30/10
|
|
Value as
of 6/30/10
|
Addex Pharmaceuticals Ltd. |
|
488,370 |
|
$ |
6,519,474 |
|
$ |
|
|
$ |
(78,812 |
) |
|
$ |
|
|
480,058 |
|
$ |
4,496,301 |
See Notes to Financial Statements.
18
THE SWISS HELVETIA FUND, INC.
|
|
|
|
|
Schedule of Investments (Unaudited)
(continued) |
|
June 30, 2010 |
4 |
|
Security valued by the Boards Pricing Committee. Restricted security not registered under the Securities Act of 1933, as amended, other than Rule 144A
securities. At the end of the period, the value of these securities amounted to $15,108,688 or 3.87% of the Funds net assets. Additional information on the restricted securities is as follows: |
|
|
|
|
|
Security
|
|
Acquisition Date
|
|
Acquisition Cost
|
Aravis Biotech II, LP |
|
July 31, 2007-June 30, 2010 |
|
1,693,367 |
Kuros Biosurgery Holding AG |
|
August 10, 2009-August 28, 2009 |
|
2,516,639 |
Novimmune SA Common Shares |
|
October 7, 2009-December 11, 2009 |
|
1,551,109 |
Novimmune SA Preferred Shares |
|
October 7, 2009-December 11, 2009 |
|
2,062,307 |
Synosia Therapeutics Holding AG |
|
October 17, 2008-February 23, 2009 |
|
1,740,545 |
Zurmont Madison Private Equity, LP |
|
September 13, 2007-June 24, 2010 |
|
8,020,652 |
|
|
|
|
|
|
|
|
|
17,584,619 |
|
|
|
|
|
5 |
|
Illiquid. There is no public market for these securities. |
6 |
|
Security priced at fair value as determined by the Boards Pricing Committee. At the end of the period, the value of these securities amounted to
$15,108,688 or 3.87% of the net assets. |
* |
|
Cost for Federal income tax purposes is $281,287,251 and net unrealized appreciation (depreciation) consists of: |
|
|
|
|
|
Gross Unrealized Appreciation |
|
$ |
111,358,815 |
|
Gross Unrealized Depreciation |
|
|
(34,748,677 |
) |
|
|
|
|
|
Net Unrealized Appreciation (Depreciation) |
|
$ |
76,610,138 |
|
|
|
|
|
|
The description of each investment shown on
the Schedule of Investments was obtained from Bloomberg as of June 30, 2010.
See Notes to Financial Statements.
19
THE SWISS HELVETIA FUND, INC.
|
|
|
|
|
Schedule of Investments
(Unaudited)
(concluded)
|
|
June 30, 2010 |
|
|
|
|
PORTFOLIO HOLDINGS |
|
|
|
% of Net Assets |
|
|
|
Common Stocks |
|
|
|
Pharmaceuticals |
|
22.0 |
% |
Food & Beverages |
|
19.6 |
% |
Industrial Goods & Services |
|
9.5 |
% |
Banks |
|
7.4 |
% |
Retailers |
|
4.5 |
% |
Insurance |
|
4.3 |
% |
Real Estate & Infrastructure |
|
4.0 |
% |
Construction & Materials |
|
2.7 |
% |
Technology |
|
2.3 |
% |
Personal & Household Goods |
|
2.2 |
% |
Diversified Manufacturing Operation |
|
2.0 |
% |
Chemicals |
|
1.9 |
% |
Biotechnology |
|
1.5 |
% |
Commercial Services |
|
1.1 |
% |
Oil & Gas |
|
0.9 |
% |
Medical Technology |
|
0.7 |
% |
Utility Suppliers |
|
0.6 |
% |
Private Equity Limited Partnerships |
|
1.9 |
% |
Convertible Corporate Bond |
|
1.6 |
% |
Preferred Stocks |
|
1.0 |
% |
Other Assets and Liabilities |
|
8.3 |
% |
|
|
|
|
|
|
100.0 |
% |
|
|
|
|
See Notes to Financial Statements.
20
THE SWISS HELVETIA FUND, INC.
|
|
|
|
|
Statement of Assets and Liabilities
(Unaudited) |
|
June 30, 2010 |
|
|
|
|
|
|
Assets: |
|
|
|
|
|
Unaffiliated investments, at value (cost $255,961,430) |
|
$ |
353,401,088 |
Affiliated investments, at value (cost $21,209,722) |
|
|
4,496,301 |
|
|
|
|
|
|
Total Investments at value (cost $277,171,152) |
|
|
357,897,389 |
|
|
|
|
|
|
Cash |
|
|
1,985,088 |
Foreign currency (cost $26,734,698)* |
|
|
27,588,262 |
Interest and dividends receivable |
|
|
20,932 |
Tax reclaims receivable |
|
|
3,530,512 |
Receivable for securities sold |
|
|
54,488 |
Prepaid expenses |
|
|
60,280 |
|
|
|
|
|
|
Total assets |
|
|
391,136,951 |
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
Capital shares payable |
|
|
472,901 |
Advisory fees payable (Note 2) |
|
|
247,228 |
Other fees payable |
|
|
14,152 |
|
|
|
|
|
|
Total liabilities |
|
|
734,281 |
|
|
|
|
|
|
Net assets |
|
$ |
390,402,670 |
|
|
|
|
|
|
Composition of Net Assets: |
|
|
|
|
|
Paid-in capital |
|
$ |
296,956,156 |
Distributable earnings |
|
|
|
|
|
Accumulated net investment income |
|
4,410,915 |
|
|
|
Accumulated net realized gain from investment, foreign currency transactions and written options |
|
7,349,198 |
|
|
|
Net unrealized appreciation on investments and foreign currency |
|
81,686,401 |
|
|
|
|
|
|
|
|
|
Total distributable earnings |
|
|
93,446,514 |
|
|
|
|
|
|
Net assets |
|
$ |
390,402,670 |
|
|
|
|
|
|
Net Asset Value Per Share: |
|
|
|
|
|
($390,402,670 ÷ 31,124,827 shares outstanding, $0.001 par value; 50 million shares authorized) |
|
$ |
12.54 |
|
|
|
|
|
|
* |
|
Foreign currency consists of 29,746,375 Swiss francs, (3,544) euros, and 5,026 British pounds. |
See Notes to Financial Statements.
21
THE SWISS HELVETIA FUND, INC.
|
|
|
|
|
Statement of Operations
(Unaudited) |
|
For the Six Months Ended June 30, 2010 |
|
|
|
|
|
Investment Income: |
|
|
|
|
Dividends (less foreign tax withheld of $1,364,948) |
|
$ |
7,732,833 |
|
Interest |
|
|
192,484 |
|
|
|
|
|
|
Total income |
|
|
7,925,317 |
|
|
|
|
|
|
Expenses: |
|
|
|
|
Investment advisory fees (Note 2) |
|
|
1,558,585 |
|
Directors fees & expenses |
|
|
231,369 |
|
Professional fees |
|
|
303,024 |
|
Administration fees |
|
|
144,889 |
|
Custody fees |
|
|
43,257 |
|
Printing and shareholder reports |
|
|
54,790 |
|
Accounting fees |
|
|
53,411 |
|
Transfer agent fees |
|
|
13,127 |
|
Miscellaneous |
|
|
250,090 |
|
|
|
|
|
|
Total expenses |
|
|
2,652,542 |
|
|
|
|
|
|
Net investment income |
|
|
5,272,775 |
|
|
|
|
|
|
Realized and Unrealized Gain (Loss) on Investments, Written Call Options and Foreign Currency: |
|
|
|
|
Net realized gain (loss) from: |
|
|
|
|
Investment transactions |
|
|
23,565,086 |
|
Foreign currency transactions (Note 1) |
|
|
(336,089 |
) |
Written call options |
|
|
(289,314 |
) |
Net change in unrealized appreciation/depreciation from: |
|
|
|
|
Investments |
|
|
(58,138,649 |
) |
Foreign currency translations |
|
|
812,398 |
|
Written call options |
|
|
(65,997 |
) |
|
|
|
|
|
Net Realized and Unrealized Gain (Loss) on Investments, Written Call Options and Foreign Currency |
|
|
(34,452,565 |
) |
|
|
|
|
|
Net Decrease in Net Assets from
Operations |
|
$ |
(29,179,790 |
) |
|
|
|
|
|
See Notes to Financial Statements.
22
THE SWISS HELVETIA FUND, INC.
|
|
|
|
|
Statement of Changes in Net Assets |
|
|
|
|
|
|
|
|
|
For the Six Months Ended June 30,
20101 |
|
For the
Year Ended December 31, 2009 |
|
|
|
|
|
|
|
|
|
Increase (Decrease) in Net Assets: |
|
|
|
|
|
|
|
|
Operations: |
|
|
|
|
|
|
|
|
Net investment income |
|
$ |
5,272,775 |
|
|
$ |
1,883,605 |
|
Net realized gain (loss) from: |
|
|
|
|
|
|
|
|
Investment transactions |
|
|
23,565,086 |
|
|
|
(10,991,829 |
) |
Foreign currency transactions |
|
|
(336,089 |
) |
|
|
7,068,023 |
|
Written call options |
|
|
(289,314 |
) |
|
|
1,612,491 |
|
Net change in unrealized appreciation/depreciation from: |
|
|
|
|
|
|
|
|
Investments |
|
|
(58,138,649 |
) |
|
|
(6,096,220 |
) |
Foreign currency translations |
|
|
812,398 |
|
|
|
(9,082,766 |
) |
Written call options |
|
|
(65,997 |
) |
|
|
65,997 |
|
|
|
|
|
|
|
|
|
|
Net decrease in net assets from operations |
|
|
(29,179,790 |
) |
|
|
(15,540,699 |
) |
|
|
|
|
|
|
|
|
|
Distributions to Stockholders from: |
|
|
|
|
|
|
|
|
Net investment income and net realized gain from foreign currency transactions |
|
|
|
|
|
|
(7,077,616 |
) |
Net realized capital gain |
|
|
|
|
|
|
(11,882,602 |
) |
|
|
|
|
|
|
|
|
|
Total distributions to stockholders |
|
|
|
|
|
|
(18,960,218 |
) |
|
|
|
|
|
|
|
|
|
Capital Share Transactions: |
|
|
|
|
|
|
|
|
Value of shares repurchased through stock buyback |
|
|
(14,343,134 |
) |
|
|
(635,755 |
) |
|
|
|
|
|
|
|
|
|
Total decrease from capital share transactions |
|
|
(14,343,134 |
) |
|
|
(635,755 |
) |
|
|
|
|
|
|
|
|
|
Total decrease in net assets |
|
|
(43,522,924 |
) |
|
|
(35,136,672 |
) |
Net Assets: |
|
|
|
|
|
|
|
|
Beginning of period |
|
|
433,925,594 |
|
|
|
469,062,266 |
|
|
|
|
|
|
|
|
|
|
End of period (including accumulated net investment income (loss) of $4,410,915 and $(861,860), respectively) |
|
$ |
390,402,670 |
|
|
$ |
433,925,594 |
|
|
|
|
|
|
|
|
|
|
See Notes to Financial
Statements.
23
THE SWISS HELVETIA FUND, INC.
Financial Highlights
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Six Months Ended June
30, 20101
|
|
|
For the Years Ended December 31,
|
|
|
|
|
2009
|
|
|
2008
|
|
|
2007
|
|
|
2006
|
|
|
2005
|
|
Per Share Operating Performance: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net asset value at the beginning of period |
|
$ |
13.39 |
|
|
$ |
14.45 |
|
|
$ |
19.34 |
|
|
$ |
20.61 |
|
|
$ |
17.47 |
|
|
$ |
16.79 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from Investment Operations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net investment income2 |
|
|
0.17 |
|
|
|
0.06 |
|
|
|
0.08 |
|
|
|
0.02 |
|
|
|
0.02 |
|
|
|
0.05 |
|
Net realized and unrealized gain (loss) on
investments3 |
|
|
(1.10 |
) |
|
|
(0.53 |
) |
|
|
(4.65 |
) |
|
|
1.98 |
|
|
|
5.14 |
|
|
|
2.24 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total from investment operations |
|
|
(0.93 |
) |
|
|
(0.47 |
) |
|
|
(4.57 |
) |
|
|
2.00 |
|
|
|
5.16 |
|
|
|
2.29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain from capital share repurchases |
|
|
0.08 |
|
|
|
|
* |
|
|
0.08 |
|
|
|
0.04 |
|
|
|
0.03 |
|
|
|
0.04 |
|
Capital charge resulting from the issuance of fund shares |
|
|
|
|
|
|
|
|
|
|
(0.08 |
) |
|
|
(1.36 |
)4 |
|
|
(0.07 |
) |
|
|
(0.04 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less Distributions: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dividends from net investment income and net realized gains from foreign currency transactions |
|
|
|
|
|
|
(0.22 |
) |
|
|
(0.08 |
) |
|
|
|
|
|
|
(0.03 |
) |
|
|
(0.02 |
) |
Distributions from net realized capital gains |
|
|
|
|
|
|
(0.37 |
) |
|
|
(0.24 |
) |
|
|
(1.95 |
) |
|
|
(1.95 |
) |
|
|
(1.59 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total distributions |
|
|
|
|
|
|
(0.59 |
) |
|
|
(0.32 |
) |
|
|
(1.95 |
) |
|
|
(1.98 |
) |
|
|
(1.61 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net asset value at end of period |
|
$ |
12.54 |
|
|
$ |
13.39 |
|
|
$ |
14.45 |
|
|
$ |
19.34 |
|
|
$ |
20.61 |
|
|
$ |
17.47 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Market value per share at the end of period |
|
$ |
10.67 |
|
|
$ |
11.62 |
|
|
$ |
12.43 |
|
|
$ |
16.50 |
|
|
$ |
19.10 |
|
|
$ |
15.31 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investment
Return5,6: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Based on market value per share |
|
|
(8.18 |
)% |
|
|
(1.20 |
)% |
|
|
(22.98 |
)% |
|
|
(3.39 |
)% |
|
|
37.64 |
% |
|
|
13.11 |
% |
Based on net asset value per share |
|
|
(6.35 |
)% |
|
|
(2.07 |
)% |
|
|
(23.62 |
)% |
|
|
4.95 |
%7 |
|
|
30.16 |
% |
|
|
14.92 |
% |
Ratios to Average Net
Assets8: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net expenses |
|
|
1.29 |
% |
|
|
1.23 |
% |
|
|
1.10 |
% |
|
|
1.10 |
% |
|
|
1.17 |
% |
|
|
1.19 |
% |
Gross expenses |
|
|
1.29 |
% |
|
|
1.23 |
% |
|
|
1.12 |
%9 |
|
|
1.10 |
% |
|
|
1.17 |
% |
|
|
1.19 |
% |
Net investment income |
|
|
2.57 |
% |
|
|
0.47 |
% |
|
|
0.49 |
% |
|
|
0.12 |
% |
|
|
0.09 |
% |
|
|
0.27 |
% |
Supplemental Data: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net assets at end of period (000s) |
|
$ |
390,403 |
|
|
$ |
433,926 |
|
|
$ |
469,062 |
|
|
$ |
621,915 |
|
|
$ |
502,815 |
|
|
$ |
419,814 |
|
Average net assets during the period (000s) |
|
$ |
414,110 |
|
|
$ |
404,535 |
|
|
$ |
554,386 |
|
|
$ |
599,573 |
|
|
$ |
484,631 |
|
|
$ |
415,074 |
|
Stockholders of record1 |
|
|
638 |
|
|
|
662 |
|
|
|
695 |
|
|
|
736 |
|
|
|
794 |
|
|
|
740 |
|
Portfolio turnover rate6 |
|
|
35 |
% |
|
|
123 |
% |
|
|
66 |
% |
|
|
26 |
% |
|
|
34 |
% |
|
|
37 |
% |
* |
|
Amount is less than $0.01 per share. |
2 |
|
Calculated using the average shares method. |
3 |
|
Includes net realized and unrealized currency gains and losses. |
4 |
|
Issued in connection with rights offering. |
5 |
|
Total investment return based on market value differs from total investment return based on net asset value due to changes in relationship between the
Funds market price and its net asset value (NAV) per share. |
6 |
|
Not annualized for periods less than one year. |
7 |
|
Not including the rights offering dilution, the NAV performance as of 12/31/07 was 12.14%. This calculation was determined by adjusting the beginning NAV in
the total return calculation by the per-share capital change resulting from the issuance of Fund shares. |
8 |
|
Annualized for periods less than one year. |
9 |
|
Reflects the expense ratio excluding any expense waivers and/or reimbursements. |
See Notes to Financial Statements.
24
THE SWISS HELVETIA FUND, INC.
Notes to Financial Statements
(Unaudited)
Note 1Organization and Significant Accounting Policies
A. Organization
The Swiss Helvetia Fund, Inc. (the Fund) is registered under the Investment Company Act of 1940, as amended (the Act), as a non-diversified,
closed-end investment management company. The Fund is organized as a corporation under the laws of the State of Delaware.
The investment objective of the Fund is to seek long-term growth of capital through investment in equity and equity-linked securities of Swiss companies. The Fund
may also acquire and hold equity and equity-linked securities of non-Swiss companies in limited instances.
B. Valuation at Securities
The Fund values
its investments at fair value.
When valuing listed equity securities, the
Fund uses the last sale price prior to the calculation of the Funds net asset value (NAV). When valuing equity securities that are not listed or that are listed but have not traded, the Fund uses the mean between the bid and asked
prices for that day.
When valuing fixed income securities, the Fund uses
the last bid price prior to the calculation of the Funds NAV. If a current bid price is not available, the Fund uses the mean between the latest quoted bid and asked prices. When valuing fixed income securities that mature within sixty days,
the Fund uses amortized cost, which approximates fair value.
It is the
responsibility of the Funds Board of Directors (the Board) to establish fair valuation procedures. When valuing securities for which market quotations are not readily available, or for which the market quotations that are available
are considered unreliable, the Fund determines a fair value in good faith in accordance with these procedures. The Fund may use these procedures to establish the fair value of securities when, for example, a significant event occurs between the time
the market closes and the time the Fund values its investments. After consideration of various factors, the Fund may value the securities at their last reported price or at some other value.
Swiss Exchange-listed options or options that are not listed at the request of
counterparty are valued using implied volatilities as input into widely accepted models (e.g., Black-Scholes). Eurex-listed options are valued at their most recent sale price (latest bid for long options and the latest ask for short options), or if
there are no such sales, at the average of the most recent bid and asked quotations, or if such quotations are not available, at the last bid quotation (in the case of purchased options) or the last asked quotation (in the case of written options);
however, if there are no such quotations, such contracts will be valued using the implied volatilities observed for similar options as an input to a model. Options traded in the over-the-counter market are valued at the price communicated by the
counterparty to the option, which typically is the price at which the counterparty would close out the transaction.
Various inputs are used to determine the value of the Funds investments. These inputs are summarized in the three broad levels listed below:
Level 1quoted prices in active markets for
identical assets and liabilities
Level 2other significant observable inputs (including quoted prices of similar
securities, interest rates, prepayment speeds, credit risk, etc.)
Level 3significant unobservable inputs
(including the Funds own assumptions in determining the fair value of investments)
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
25
THE SWISS HELVETIA FUND, INC.
Notes to Financial Statements (Unaudited)
(continued)
The following is a summary of the inputs used to value the Funds net assets as of June 30, 2010:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Level
1 Quoted Prices
|
|
Level
2 Other Significant Observable Inputs
|
|
Level 3
Significant Unobservable Inputs
|
|
Total
|
Investments in Securities |
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock* |
|
$ |
336,580,141 |
|
$ |
|
|
$ |
4,010,757 |
|
$ |
340,590,898 |
Preferred Stock |
|
|
|
|
|
|
|
|
3,832,520 |
|
|
3,832,520 |
Convertible Corporate Bond |
|
|
|
|
|
6,208,560 |
|
|
|
|
|
6,208,560 |
Private Equity Investments |
|
|
|
|
|
|
|
|
7,265,411 |
|
|
7,265,411 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Investments in Securities |
|
$ |
336,580,141 |
|
$ |
6,208,560 |
|
$ |
15,108,688 |
|
$ |
357,897,389 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* |
Please see the Schedule of Investments for Industry classifications. |
The inputs and valuation techniques used to value Level 2 securities, which consist of
an exchange-listed corporate convertible bond, are based on a pricing service model, which may include consideration of dealer quotes, trade execution data, conversion prices compared to the current market quotation of the underlying stock and, when
available, the last sale price on the exchange on which it trades.
Level 3
securities consist of direct investments in privately-held companies and investments in private equity funds. Privately-held companies and underlying securities in private equity funds are valued according to International Financial Reporting
Standards (IFRS) and European Venture Capital Association (EVCA) principles. The inputs and valuation techniques used to value Level 3 securities may include the following: acquisition cost; size of the investment; fundamental analytical data;
nature and duration of restrictions on disposition of the investment; public trading of similar securities of similar issuers; economic outlook and condition of the industry in which the issuer participates; financial condition of the issuer; and
the issuers prospects, including any recent or potential management or capital structure changes. For the private equity funds, inputs and valuation techniques also may include fair valuations of the funds and their portfolio holdings provided
by the underlying funds managers, other available information about the funds portfolio holdings, values obtained on redemption from other investors in an underlying fund, discussions with the underlying funds managers and/or other
investors and comparisons of previously-obtained estimates against the funds audited financial statements.
When valuing Level 3 investments, management also considers potential events that could have a material impact on their operations. Not all of these factors may be
considered or available, and other relevant factors may be considered on an investment-by-investment basis.
In January 2010, Financial Accounting Standards Board issued Accounting Standards Update 2010-06 (ASU 2010-06) to ASC 820-10, Fair Value
Measurements and Disclosures. New disclosures and clarifications of existing disclosures are effective for interim periods while disclosures about purchases, sales, issuances, and settlements in the Level 3 roll forward of activity in fair
value measurements are effective for interim and fiscal periods beginning after December 15, 2010. The Fund has adopted a policy of recognizing transfers between Level 1 and Level 2 based on their market prices at the reporting period end. For
the six-month period ended June 30, 2010, there were no significant transfers between Levels.
The following is a reconciliation of Level 3 assets for which significant unobservable inputs were used to determine fair value.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock
|
|
|
Preferred Stock
|
|
|
Private Equity Investments
|
|
Balance as of December 31, 2009 |
|
$ |
4,183,797 |
|
|
$ |
3,997,870 |
|
|
$ |
7,395,960 |
|
Change in Unrealized Appreciation/Depreciation |
|
|
(173,040 |
) |
|
|
(165,350 |
) |
|
|
(394,304 |
) |
Net Purchases/(Sales) |
|
|
|
|
|
|
|
|
|
|
263,755 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance as of June 30, 2010 |
|
$ |
4,010,757 |
|
|
$ |
3,832,520 |
|
|
$ |
7,265,411 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
26
THE SWISS HELVETIA FUND, INC.
Notes to Financial Statements (Unaudited)
(continued)
C. Securities Transactions and Investment Income
Securities transactions are recorded on the trade date. Realized gains and losses are determined by comparing the proceeds of a sale or the cost of a purchase with
a specific offsetting transaction.
Dividend income, net of any foreign
taxes withheld, is recorded on the ex-dividend date. Interest income, including amortization of premiums and accretion of discounts, is accrued daily. Estimated expenses are also accrued daily.
The Fund records Swiss withholding tax as a reduction of dividend income, net of any
amount reclaimable from Swiss tax authorities in accordance with the tax treaty between the United States and Switzerland.
D. Distributions
The Fund pays dividends at
least annually to the extent it has any net investment income and net realized gains from foreign currency transactions and makes distributions of any net realized capital gains to the extent they exceed any capital loss carryforwards. The Fund
determines the size and nature of these distributions in accordance with provisions of the Internal Revenue Code. Distributions may be paid either in cash or in stock with an option to take cash. The Fund records dividends and distributions on the
ex-dividend date.
E. Federal Income Taxes
The Funds policy is to continue to comply with the requirements of the Internal Revenue Code that are applicable to regulated investment
companies and to distribute all its taxable income to its stockholders. Therefore, no federal income tax provision is required.
Income and capital gain distributions are determined in accordance with federal income tax regulations, which may differ from generally accepted accounting
principles. See Note 5 for federal income tax treatment of foreign currency gain/losses.
Management has analyzed the Funds tax positions taken on federal income tax returns for all open tax years and has concluded that no provision for federal
income tax is required in the Funds financial statements. The Fund files U.S. federal, Delaware state and foreign tax returns. The Funds U.S. federal tax returns remain open for examination for the years ended December 31, 2006
through December 31, 2009. The Funds Delaware state tax returns remain open for examination for the years ended December 31, 2005 through December 31, 2009. In addition, the Fund holds investments in Switzerland and other
foreign tax jurisdictions that remain open subject to examination based on varying statutes of limitations.
F. When Issued and Delayed Delivery Transactions
The Fund may purchase or sell securities on a when-issued or delayed delivery basis. The Fund records when-issued or delayed delivery securities as of trade date
and maintains security positions such that sufficient liquid assets will be available to make payment for the securities purchased. The Fund may dispose of or renegotiate a delayed delivery transaction after it is entered into, which may result in a
capital gain or loss. Losses may occur on these transactions due to changes in market conditions or the failure of counterparties to perform under the contract.
G. Options
The Fund may buy call options and
put options, and may sell (write) covered call options. Options may be entered into on securities in which the Fund may invest and on Swiss stock indices. Option contracts are utilized to manage the Funds exposure to changing security prices
and to generate income. Purchasing call options tends to increase the Funds exposure to the underlying instrument. Purchasing put options tends to decrease the Funds exposure to the underlying instrument. The Fund pays a premium as an
investment that is subsequently marked-to-market to reflect the current value of the option. Premiums paid for purchasing options which expire are treated as realized losses. The risk associated with purchasing put and call options is limited to the
premium paid. Premiums paid for purchasing options which are exercised or closed are added to the amounts paid or offset against the proceeds on the underlying instrument to determine the realized gain or loss.
27
THE SWISS HELVETIA FUND, INC.
Notes to Financial Statements (Unaudited)
(continued)
Writing call options tends to decrease the Funds exposure to the underlying instrument. When the Fund writes
a call option, such option is covered, meaning that the Fund holds the underlying instrument subject to being called by the option counterparty. When the Fund writes a call option, an amount equal to the premium received is recorded as a
liability and subsequently marked-to-market to reflect the current value of the option written. Premiums received from writing options which expire are treated as realized gains.
Premiums received from writing options which are exercised or closed are added to the
proceeds or offset against amounts paid on the underlying instrument to determine the realized gain or loss. The Fund as a writer of an option has no control over whether the underlying instrument may be sold (call) and, as a result, bears the
market risk of an unfavorable change in the price of the instrument underlying the written option. There is the risk the Fund may not be able to enter into a closing transaction because of an illiquid market.
Transactions in written call options during the period ended June 30, 2010, were
as follows:
|
|
|
|
|
|
|
|
|
|
Number of Contracts
|
|
|
Premium Received
|
|
Outstanding, December 31, 2009 |
|
30,000 |
|
|
$ |
762,490 |
|
Written |
|
|
|
|
|
|
|
Exercised |
|
|
|
|
|
|
|
Expired |
|
|
|
|
|
|
|
Closed |
|
(30,000 |
) |
|
|
(762,490 |
) |
|
|
|
|
|
|
|
|
Outstanding, June 30, 2010 |
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
Market Value of Liability, June 30, 2010 |
|
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
The Fund held no contracts at June 30, 2010. There was no effect of derivative instruments on the Statement of Assets and Liabilities as of June 30, 2010.
The effect of derivative instruments on the Statement of Operations for
the period ended June 30, 2010:
|
|
|
|
|
|
|
|
|
|
|
Derivatives not accounted for as hedging
instruments
|
|
Location of Gain (Loss) on Derivatives Recognized in
Income
|
|
Realized Gain (Loss)
on Derivatives Recognized in Income
|
|
|
Change in Unrealized Appreciation (Depreciation)
on Derivatives Recognized in Income
|
|
Equity Contracts |
|
Net Realized gain (loss) from written call options/Net change in unrealized appreciation/depreciation from written call
options |
|
$ |
(289,314 |
) |
|
$ |
(65,997 |
) |
|
|
Net Realized gain (loss) from investment transactions/Net change in unrealized appreciation/depreciation from
investments |
|
|
(14,318,999 |
) |
|
|
11,850,880 |
|
H. Foreign Currency Translation
The Fund
maintains its accounting records in U.S. dollars. The Funds assets are invested primarily in Swiss equities and equity-linked securities. In addition, the Fund makes its temporary investments in Swiss franc-denominated bank deposits,
short-term debt securities and money market instruments. Substantially all income received by the Fund is in Swiss francs. The Funds NAV, however, is reported, and distributions from the Fund are made, in U.S. dollars resulting in gain or loss
from currency conversions in the ordinary course of business. Historically, the Fund has not entered into transactions designed to reduce currency risk and does not intend to do so in the future. The cost basis of foreign denominated assets and
liabilities is determined on the date that they are first recorded within the Fund and translated to U.S. dollars. These assets and liabilities are subsequently valued each day at
28
THE SWISS HELVETIA FUND, INC.
Notes to Financial Statements (Unaudited)
(continued)
prevailing exchange rates. The difference between the original cost and current value denominated in U.S. dollars is recorded as unrealized foreign currency gain/loss. In valuing assets and
liabilities, the Fund uses the prevailing exchange rate on the valuation date. In valuing securities transactions, the receipt of income and the payment of expenses, the Fund uses the prevailing exchange rate on the transaction date.
Net realized and unrealized gains and losses on foreign currency translations shown on
the Funds financial statements result from the sale of foreign currencies, from currency gains or losses realized between the trade and settlement dates on securities transactions, and from the difference between the amounts of dividends,
interest, and foreign withholding taxes recorded on the Funds books and the U.S. dollar equivalent of the amounts actually received or paid.
When calculating realized and unrealized gains or losses on equity investments, the Fund does not separate the gain or loss attributable to changes in the foreign
currency price of the security from the gain or loss attributable to the change in the U.S. dollar value of the foreign currency. Other foreign currency transactions resulting in realized and unrealized gain (loss) are disclosed separately.
I. Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from
those estimates.
J. Concentration of Market Risk
The Fund primarily invests in securities of Swiss issuers. Such investments may carry certain risks not ordinarily associated with investments in
securities of U.S. issuers. These risks include future political and economic developments, unfavorable movements in the U.S. dollar relative to the Swiss franc, and the possible imposition of exchange controls and changes in governmental law and
restrictions. In addition, concentrations of investments in securities of issuers located in a specific region exposes the Fund to the economic and government policies of that region and may increase risk compared to a fund whose investments are
more diversified.
Note 2Fees and
Transactions with Affiliates
Hottinger Capital Corp. (HCC), which is owned jointly by Hottinger U.S., Inc. and Hottinger & Cie
(Zurich), is the Funds advisor (the Advisor). The Fund pays the Advisor an annual fee based on its month-end net assets which is calculated and paid monthly at the following annual rates: 1.00% of the first $60 million, 0.90% of
the next $40 million, 0.80% of the next $100 million, 0.70% of the next $100 million, 0.65% of the next $100 million, 0.60% of the next $100 million, 0.55% of the next $100 million, 0.50% of next $200 million, and 0.45% of such assets in excess of
$800 million. The Fund paid Hottinger & Cie (Zurich) $63,264 in brokerage commissions for the six months ended June 30, 2010.
The Fund and the Advisor have agreed to share equally certain common expenses subject to review by the Audit Committee of the Board. During the six months ended
June 30, 2010, $8,825 of expenses incurred in connection with publicizing the Fund were shared equally by the Fund and the Advisor.
Certain officers and directors of the Fund are also officers or directors of HCC, Hottinger U.S., Inc. and Hottinger & Cie (Zurich). These persons are not
paid by the Fund for serving in these capacities.
Note 3Other Fees
Citi
Fund Services Ohio, Inc. (Citi) provides certain administration and portfolio accounting services to the Fund. The Fund pays Citi an annual fee, which is accrued daily and paid monthly.
29
THE SWISS HELVETIA FUND, INC.
Notes to Financial Statements (Unaudited)
(continued)
American Stock Transfer & Trust Company is the Funds transfer agent. The Fund pays the transfer
agent an annual fee, which is accrued daily and paid monthly.
Citibank,
N.A. serves as the Funds custodian (the Custodian), and the Fund pays the custodian an annual fee.
The Fund pays each Director who is not an interested person (as such term is defined in the Act) of the Fund or its Advisor $32,809 per annum in compensation,
except for the Chairman of the Board to whom the Fund pays an annual fee of $44,809 and for the Chairs of the Audit, the Pricing and the Governance/Nominating Committee (Committee) to each of whom the Fund pays an annual fee of $37,809.
In addition, the Fund pays each disinterested Director $1,300 for each Board meeting attended, and pays each disinterested Director who is a member of a Committee a fee of $750 for each Committee meeting attended. Committee meeting fees are paid for
only those meetings held separately from other meetings. The Board or a Committee may establish ad hoc committees or sub-committees. Any Committee or sub-committee member may be compensated by the Fund for incremental work outside of the regular
meeting process based on the value added to the Fund. In addition, the Fund reimburses Directors who are not employees of or affiliated with the Advisor for out-of-pocket expenses incurred in conjunction with attendance at meetings.
Directors fees and expenses of $231,369 shown on the Statement of Operations
represent the portion of Directors fees and expenses accrued during the period January 1, 2010 through June 30, 2010. These fees are calculated by projecting Directors fees contractually owed and adding estimates of
reimbursable expenses based on historical activity.
Note 4Capital Share Transactions
The Fund is authorized to issue up to 50 million shares of capital stock. HCC owned 205,411 of the 31,124,827 shares outstanding on June 30, 2010.
Transactions in capital shares were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Six Months Ended June 30, 2010
|
|
|
For the Year Ended December 31, 2009
|
|
|
|
Shares
|
|
|
Amount
|
|
|
Shares
|
|
|
Amount
|
|
Dividends Reinvested |
|
|
|
|
$ |
|
|
|
|
|
|
$ |
|
|
Repurchased |
|
(1,286,600 |
) |
|
|
(14,343,134 |
) |
|
(54,700 |
) |
|
|
(635,755 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Decrease |
|
(1,286,600 |
) |
|
$ |
(14,343,134 |
) |
|
(54,700 |
) |
|
$ |
(635,755 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note 5Federal Income Tax and Investment Transactions
Reclassifications are made to the Funds capital accounts to reflect income and gains available for distribution (or available capital loss carryforward) under
income tax regulations. The tax character of distributions paid during the year and the tax components of net assets will be updated at the Funds fiscal year-end.
Under current tax law, capital losses realized after October 31 of a Funds fiscal year may be deferred and treated as occurring on the first
business day of the following year for tax purposes. The Fund had $1,123,591 of deferred post October capital and currency losses, which will be treated as arising on the first business day of the fiscal year ending December 31, 2010.
At December 31, 2009, the Fund had capital loss carryovers of $12,154,834
expiring December 31, 2017.
The tax character of distributions paid during
2009 was as follows:
|
|
|
|
|
|
2009
|
Ordinary Income |
|
$ |
7,078,281 |
Long-Term Capital Gains |
|
|
11,881,937 |
|
|
|
|
|
|
$ |
18,960,218 |
|
|
|
|
30
THE SWISS HELVETIA FUND, INC.
Notes to Financial Statements (Unaudited)
(continued)
At December 31, 2009, the components of distributable earnings on a tax basis were as follows:
|
|
|
|
|
Undistributed Ordinary Income |
|
$ |
192,318 |
|
Accumulated Capital and Other Losses |
|
|
(13,278,425 |
) |
Unrealized Appreciation |
|
|
135,712,411 |
|
|
|
|
|
|
Total |
|
$ |
122,626,304 |
|
|
|
|
|
|
Gains from foreign currency transactions are treated as ordinary income for Federal income tax purposes.
The aggregate cost of purchases and proceeds from sales of investments, other than
short-term obligations, for the period ended June 30, 2010 were $139,093,927 and $165,690,949, respectively.
Note 6Stock Repurchase Program
Pursuant to authorization by the Board, the Fund began open market purchases of its common stock on the New York Stock Exchange (NYSE) in 1999 and has
continued to adopt a stock repurchase program permitting such purchases in each subsequent year. The principal purpose of the stock repurchase program is to enhance stockholder value by increasing the Funds net asset value per share without
creating a meaningful adverse effect upon the Funds expense ratio. On December 23, 2009, the Fund announced a stock repurchase program effective for the duration of 2009 and 2010. Under the program, the Fund is authorized to make
open-market repurchases of its common stock of up to $30 million. The Fund expects to repurchase its common stock when the discount to net asset value of the trading price of its common stock on NYSE is greater than 5% subject to various factors,
including the limitations imposed by the federal securities laws governing the repurchase of an issuers stock by the issuer and the ability of the Advisor to raise cash to repurchase shares of the Funds common stock in a tax-efficient
manner. During the period from January 1, 2010 through June 30, 2010, the Fund repurchased and retired 1,286,600 shares at an average price of $11.15 per share (including brokerage commissions) and at a weighted average discount of 14.25%.
These repurchases, which had a total cost of $14,343,134 (including brokerage commissions), resulted in an increase of $2,382,688 to the Funds net asset value. This gain is a result of the difference between the Funds net asset value and
the price of repurchases.
Note
7Private Equity and Other Illiquid Direct Investments
The Fund is permitted to invest in alternative investments that do not have a readily
determinable fair value and, as such, has elected to use the practical expedient as calculated on the reporting entitys measurement date as the fair value of the investment. A listing of the investments held by the Fund and their attributes as
of June 30, 2010 that qualify for these valuations are shown in the table below.
As of June 30, 2010, the Fund invested in private equity funds (limited partnerships). The Funds investments are summarized in the Schedule of
Investments. The Funds capital commitments and the amount disbursed to the private equity funds are shown in the table below:
|
|
|
|
|
|
|
|
|
|
Private Equity FundsInternational (a)
|
|
Original Capital Commitment*
|
|
Unfunded Commitments
|
|
Fair Value as of June 30,
2010
|
Zurmont Madison Private Equity LP |
|
$ |
12,982,798 |
|
$ |
5,158,054 |
|
$ |
5,635,711 |
Aravis Biotech II LP |
|
|
3,013,864 |
|
|
1,282,098 |
|
|
1,629,700 |
* |
The original capital commitment represents 14,000,000 and 3,250,000 Swiss francs for Zurmont Madison Private Equity LP and Aravis Biotech II LP, respectively. The exchange
rate as of June 30, 2010 was used for conversion and equals 1.0784. |
(a) |
This category includes two private equity funds that invest primarily in ventures, biotechnology and in management buyout of industrial and consumer goods companies. There is
no redemption right for the interests in these two funds. Instead, the nature of the investments in this category is that distributions are received through the realization of the underlying assets of a fund. If these investments were held, it is
estimated that the underlying assets of each fund would be realized over 4 to 6 years. |
31
THE SWISS HELVETIA FUND, INC.
Notes to Financial Statements (Unaudited)
(concluded)
Note 8Subsequent Events
Management has evaluated subsequent events through the date this report was available to be issued.
Pursuant to the Funds current stock repurchase program, the Fund has continued
to repurchase shares of its common stock. During the period from July 1, 2010 through August 10, 2010, the Fund repurchased and retired 219,900 shares at an average price of $11.14 per share (including brokerage commissions) and at a weighted
average discount of 14.26%. These repurchases, which had a total cost of $2,449,064 (including brokerage commissions), resulted in an increase of $407,157 to the Funds net asset value. This gain is a result of the difference between the
Funds net asset value and the price of the repurchases.
32
THE SWISS HELVETIA FUND, INC.
Additional Information
(Unaudited)
This report is sent to the stockholders of the Fund for their information. It is not a prospectus, circular
or representation intended for use in the purchase or sale of shares of the Fund or of any securities mentioned in this report.
Advisory Agreement Approval
At
a meeting on June 15, 2010 the Funds Independent Directors met in executive session to consider the proposal to approve a renewal of the Funds Investment Advisory Agreement (the Agreement) with HCC. They carefully evaluated
information that they deemed necessary to enable them to determine that the continuation of the Agreement would be in the best interests of the Fund and its stockholders. Their evaluation included information concerning the Funds performance
and expenses (including the fees paid to HCC for its services), the nature, extent and quality of the services HCC provided to the Fund, the financial position and profitability of HCC, and other benefits that HCC or its parent derived from managing
the Fund. In addition, the Directors considered the impact of the Supreme Courts decision on board responsibilities with respect to considering investment advisory agreements.
The Independent Directors reviewed the Funds investment
performance, determining that the relevant measures should be in terms of its net asset value as measured in Swiss francs because the Funds portfolio securities and cash were denominated in Swiss francs and because, as a matter of policy, the
Fund did not hedge its currency exposure. On that basis, the Independent Directors compared the Funds one-, three-and five-year investment performance as well as its longer term performance with the performance of (i) the Swiss Performance
Index (SPI), (ii) a peer group of Swiss equity investment funds of comparable or larger size managed
by Swiss advisers with publicly available performance information, (iii) the Swiss iShares traded on the New York Stock Exchange, and (iv) the Swiss Market Index (the SMI), another,
less diversified, Swiss market index. In comparing the Funds performance with the performance of the SPI and the SMI, the Independent Directors considered the fact that, unlike the Fund, the performance of the indices did not include the
impact of any expenses. The Independent Directors noted that the Fund significantly underperformed the Swiss market indices and Swiss iShares during 2009 and discussed with HCC the reasons for that underperformance, which HCC attributed to
implementing and maintaining a significant defensive posture through the purchase of put options and maintaining a significant cash position in the first half of 2009. The Independent Directors noted that during the second half of the year the
Funds purchase of call options, including those used to equitize its cash, at a time of declining market volatility, compounded by other technical factors relating to the options market, further contributed to the Funds underperformance.
The Independent Directors also considered the steps HCC took to address that underperformance, including the addition of staff and limitations on the use of options as well as enhanced compliance policies regarding such use. The Independent
Directors also noted that for the five months ended May 31, 2010, the Fund slightly outperformed the SPI, the SMI, Swiss iShares and the majority of the peer group. As a result of this evaluation, the Independent Directors concluded that, while the
Funds performance during 2009 was unsatisfactory relative to its peers and its current benchmark, the SPI, its investments were consistent with its management philosophy and the Funds performance for the cumulative period from December
31, 1996 to May 31, 2010 was in the aggregate above that of its peer group for the same period and almost 19% above the return of Swiss iShares during that
33
THE SWISS HELVETIA FUND, INC.
Additional Information (Unaudited)
(continued)
period and over 40% above the return of the SMI during that period despite being approximately 22% below the SPI for that period. The Independent Directors determined that the Funds
performance during 2009 was an aberration and that overall performance was satisfactory.
The Independent Directors noted that even though the market price per share of the Fund was lower than its net asset value per share, as
has been the case in the past, they determined that this was essentially unrelated to HCCs investment performance.
The Independent Directors also evaluated the fees HCC charged the Fund for investment advisory services as compared to the fees paid by
U.S. registered closed-end European country funds. The Independent Directors determined that the fees paid to HCC, even when combined with the seven basis point administration fee paid to the Funds unaffiliated Administrator, were among the
lowest in each group. The Independent Directors determined that the combined investment advisory fee and administration fee was also lower than the fees HCCs parent charged to its private advisory clients and to a Luxembourg-based fund it
managed with similar investment objectives and strategies.
The Independent Directors separately considered the fees charged by HCC including breakpoints at various asset levels. They noted that
breakpoints allowed the Fund to share in economies of scale as its asset base grew. They further noted that in 2008 HCC had voluntarily offered and had agreed to further adjust the breakpoints in its fees by introducing a new breakpoint of 0.45% of
month-end net assets in excess of $800 million at a time when Fund assets were $624 million. As a result of the general market decline, the Funds net assets at May 31, 2010 were $372 million.
The Independent Directors evaluated the nature of the Fund, the creativity of HCC in
developing the Funds investment strategies, and the complexity of the Swiss securities market. The Independent Directors acknowledged that expansion of the Funds investment policies over the past few years to permit investments in
private equity and real estate, the use of options and the need to manage the rights offering proceeds accordingly, had required additional effort on the part of HCC. The Independent Directors determined that HCCs services to the Fund were
highly professional and that the qualifications and number of HCC personnel, the availability of company research and market and financial information from HCCs parent in Switzerland were all desirable factors, noting in particular Hottinger
groups strengthening of its investment process. The Independent Directors considered the change during 2009 of the chief executive officer of HCC and the Hottinger groups commitment to his continuance in that role as well as other
matters relating to HCCs parent, including that the Hottinger group had repeated its intention to continue to support HCC and had made significant progress towards its internal reorganization. The Independent Directors also considered that HCC
had increased its staff in 2010, adding experienced portfolio management personnel.
The Independent Directors considered the financial condition of HCC, noting that the advisory fees it received from the Fund comprised the
majority of its revenue. The Independent Directors concluded that HCCs financial condition was sound and that, although it was not profitable in 2009 due to the reduced levels of fee income from the Fund, the fees from the Fund were reasonable
for the services it provided to the Fund. The Independent Directors considered other benefits that HCC or its parent could be considered to derive from its relationship with the Fund including very limited brokerage
com-
34
THE SWISS HELVETIA FUND, INC.
Additional Information (Unaudited)
(continued)
missions from executing Fund transactions, and the marketing value of the Funds performance in attracting other clients. The Independent Directors determined that these benefits were
relatively minor and did not affect their overall assessment of the reasonableness of the relationship.
Based on the evaluation of these factors and the assistance of independent legal counsel, the Independent Directors concluded that the
Funds advisory fee rate was reasonable in relation to the service rendered by HCC and therefore approved the continuation of the Agreement.
Results of Annual Meeting of Stockholders
There were 31,525,227 shares of the Funds common stock eligible to vote at the Funds 2010 Annual Meeting of Stockholders held on June 16,
2010. At the Meeting, a quorum was present in person or by proxy and the Funds shares were voted on the Proposals presented to the Funds Stockholders as follows:
1. To elect four Class I Directors to serve for a three year term until the
2013 Annual Meeting of Stockholders:
|
|
|
|
|
|
|
|
|
|
For
|
|
Withheld
|
|
Approval (%)
|
|
Jean-Marc Boillat |
|
17,426,619 |
|
9,129,805 |
|
65.62 |
% |
Claude W. Frey |
|
17,455,697 |
|
9,100,727 |
|
65.73 |
% |
R. Clark Hooper |
|
17,388,565 |
|
9,167,859 |
|
65.48 |
% |
Alexandre de Takacsy |
|
17,256,825 |
|
9,299,599 |
|
64.98 |
% |
2. To ratify the selection by the Board of Directors of Deloitte & Touche LLP as the Funds independent registered public accounting firm
for the year ending December 31, 2010:
|
|
|
|
|
|
|
|
For
|
|
Against
|
|
Abstain
|
|
Approval (%)
|
|
25,512,839 |
|
735,577 |
|
308,008 |
|
96.07 |
% |
3. To approve a stockholder proposal asking the Board of Directors to take the steps necessary to convert
the Fund from a closed-end fund to an interval fund, as outlined in the Funds proxy materials:
|
|
|
|
|
|
|
|
For (out of 31,525,227 shares)
|
|
Against
|
|
Abstain
|
|
Approval (%)
|
|
9,703,826 |
|
7,661,746 |
|
720,483 |
|
53.65 |
% |
Of the Funds shares that voted FOR Proposal 3, over 80% (7,873,871 out of 9,703,826) were voted by two institutional
investors. Other than shares voted by those two investors, only 6% of the Funds shares were voted FOR Proposal 3.
Approval percentages are based on the total number of votes cast on a particular Proposal. Not all shares eligible to vote on each
Proposal did so. Broker non-votes were considered shares present for purposes of determining a quorum but were not voted in favor of a Proposal.
Proxy Voting Information
A
description of the policies and procedures that the Fund uses to determine how to vote proxies relating to portfolio securities is available, without charge and upon request, by calling 1-888-SWISS-00 and on the SECs website at
http://www.sec.gov. The Funds proxy voting record for the twelve-month period ended June 30 is available, without charge and upon request, by calling 1-888-SWISS-00 and on the SECs website at http://www.sec.gov.
Availability of Quarterly Portfolio Schedules
The Fund files its complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year on Form N-Q. The Funds
Form N-Q is available, without charge and upon
35
THE SWISS HELVETIA FUND, INC.
Additional Information (Unaudited)
(concluded)
request, on the SECs website at http:// www.sec.gov or may be reviewed and copied at the SECs Public Reference Room in Washington, DC. Information on the operation of the Public
Reference Room may be obtained by calling (800) SEC-0330.
Code of Ethics
The Board of
Directors of the Fund and the Advisor have adopted Codes of Ethics (the Codes) pursuant to provisions of the Investment Company Act of 1940. The Codes apply to the personal investing activities of various individuals including directors
and officers of the Fund and designated officers, directors and employees of the Advisor. The provisions of the Codes place restrictions on individuals who are involved in managing the Funds portfolio, who help execute the portfolio
managers decisions or who come into possession of contemporaneous information concerning the investment activities of the Fund.
The fundamental principle of the Codes is that the individuals covered by the Codes have a fiduciary responsibility to the Fund and its
stockholders. They are therefore required at all times to place the interests of the Fund and the
stock-
holders first and to conduct all personal securities transactions in a manner so as to avoid any actual or potential conflict of interest or abuse of their position of trust.
Portfolio managers and other individuals with knowledge of
Fund investment activities are prohibited from purchasing or selling a security during a blackout period of 30 calendar days before and after the date on which the Fund affects a trade in the same or a similar security. They are also prohibited from
engaging in short term trading of Swiss equity or equity linked securities.
Additionally, the Funds portfolio managers are prohibited from participating in any initial public offering or private placement of
Swiss equity and equity linked securities and other covered individuals must obtain prior clearance before doing so.
Any individual who violates the provisions of the Codes is required to reverse the transaction and to turn over any resulting profits to
the Fund. The Fund and the Advisor have adopted compliance procedures and have appointed compliance officers to ensure that all covered individuals comply with the Codes.
36
THE SWISS HELVETIA FUND, INC.
Dividend Reinvestment Plan
(Unaudited)
The Plan
The Funds Dividend Reinvestment Plan (the Plan) offers a convenient way for you to reinvest capital gains distributions and ordinary
income dividends, payable in whole or in part in cash, in additional shares of the Fund.
Some of the Plan features are:
|
|
|
Once you enroll in the Plan, all of your future distributions and dividends payable in whole or in part in cash will be automatically reinvested in
Fund shares in accordance with the terms of the Plan. |
|
|
|
You will receive shares valued at the lower of the Funds net asset value or the Funds market price as described below. The entire amount of
your distribution or dividend will be reinvested automatically in additional Fund shares. For any balance that is insufficient to purchase full shares of the Fund, your account will be credited with fractional shares. |
|
|
|
Your shares will be held in an account with the Plan agent. You will be sent regular statements for your records. |
|
|
|
You may terminate participation in the Plan at any time. |
The following are answers to frequently asked questions about
the Plan.
How do I enroll in the Plan?
If you are holding certificates for your shares, contact American Stock Transfer & Trust Company (AST) at the address shown below. If
your shares are held in a brokerage account, contact your broker. Not all brokerage firms permit their clients to participate in dividend reinvestment plans such as the Plan and, even if your brokerage firm does permit participation, you may not be
able to transfer your Plan shares to another
broker who does not permit participation. Your brokerage firm will be able to advise you about its policies.
How does the Plan work?
The cash portion of any dividends or distributions you receive, payable in whole or in part in cash, will be reinvested in shares of the Fund. The number
of shares credited to your Plan account as a result of the reinvestment will depend upon the relationship between the Funds market price and its net asset value per share on the record date of the distribution or dividend, as described below:
|
|
|
If the net asset value is greater than the market price (the Fund is trading at a discount), AST, as Plan Agent, will buy Fund shares for your account
on the open market on the New York Stock Exchange or elsewhere. Your dividends or distributions will be reinvested at the average price AST pays for those purchases. |
|
|
|
If the net asset value is equal to the market price (the Fund is trading at parity), the Fund will issue for your account new shares at net asset
value. |
|
|
|
If the net asset value is less than but within 95% of the market price (the Fund is trading at a premium of less than 5%), the Fund will issue for your
account new shares at net asset value. |
|
|
|
If the net asset value is less than 95% of the market price (the Fund is trading at a premium of 5% or more), the Fund will issue for your account new
shares at 95% of the market price. |
If AST
begins to buy Fund shares for your account at a discount to net asset value but, during the course of the purchases, the Funds market price increases to a level above the net asset
37
THE SWISS HELVETIA FUND, INC.
Dividend Reinvestment Plan (Unaudited)
(concluded)
value, AST will complete its purchases, even though the result may be that the average price paid for the purchases exceeds net asset value.
Will the entire amount of my distribution or dividend be
reinvested?
The entire amount of your distribution or dividend, payable in cash, will be reinvested in additional Fund shares. If a balance
remains after the purchase of whole shares, your account will be credited with any fractional shares (rounded to three decimal places) necessary to complete the reinvestment.
How can I sell my shares?
You can sell any or all of the shares in your Plan account by contacting AST. AST charges $15 for the transaction plus $.10 per share for this service.
You can also withdraw your shares from your Plan account and sell them through your broker.
Does participation in the Plan change the tax status of my distributions or dividends?
No. The distributions and dividends are paid in cash and their taxability is the same as if you received the cash. It is only after the payment of
distributions and dividends that AST reinvests the cash for your account.
Can I get certificates for the shares in the Plan?
AST will issue certificates for whole shares upon your request. Certificates for fractional shares will not be issued.
Is there any charge to participate in the Plan?
There is no charge to participate in the Plan. You will, however, pay a pro rata share of brokerage commissions incurred with respect to ASTs open
market purchases of shares for your Plan account.
How can I discontinue my participation in the Plan?
Contact your broker or AST in writing. If your shares are in a Plan account, AST will send you a certificate for your whole shares and a check for any
fractional shares.
Where can I direct my
questions and correspondence?
Contact your broker, or contact AST as follows:
By mail:
American Stock Transfer & Trust
Company
PO Box
922
Wall Street Station
New York, NY 10269-0560
Through the Internet:
www.amstock.com
Through ASTs automated voice response System:
1-888-556-0425
AST will furnish you with a copy of the Terms and Conditions of the Plan without charge.
38
A
Swiss Investments Fund
THE SWISS
HELVETIA FUND, INC.
Executive Offices
The Swiss Helvetia Fund, Inc.
1270 Avenue of the Americas
Suite 400
New
York, New York 10020
1-888-SWISS-00
(212) 332-2760
www.swz.com
THE SWISS
HELVETIA
FUND, INC.
www.swz.com
Semiannual Report
For the
Six Months Ended
June 30, 2010
Not applicable.
Item 3. |
Audit Committee Financial Expert. |
Not
applicable.
Item 4. |
Principal Accountant Fees and Services. |
Not applicable.
Item 5. |
Audit Committee of Listed Registrants. |
Not applicable.
Item 7. |
Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies. |
Not applicable.
Item 8. |
Portfolio Managers of Closed-End Management Investment Companies. |
Not applicable.
Item 9. |
Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers. |
|
|
|
|
|
|
|
|
|
|
Period |
|
(a) Total Number of Shares
Purchased |
|
(b) Average Price Paid per
Share |
|
(c) Total Number of Shares
(or Units) Purchased as Part of Publicly Announced Plans or
Programs |
|
(d) Maximum Number (or
Approximate Dollar Value)
of Shares that May Yet Be
Purchased Under the Plans or Programs |
|
|
|
|
|
|
|
|
$ |
29,364,245 |
01/01/1001/31/10 |
|
297,200 |
|
11.5273 |
|
297,200 |
|
|
25,943,452 |
02/01/1002/28/10 |
|
316,700 |
|
11.0258 |
|
316,700 |
|
|
22,447,624 |
03/01/1003/31/10 |
|
172,300 |
|
11.5707 |
|
172,300 |
|
|
20,450,482 |
04/01/1004/30/10 |
|
100,000 |
|
11.9640 |
|
100,000 |
|
|
19,251,742 |
05/01/1005/31/10 |
|
143,800 |
|
10.3586 |
|
143,800 |
|
|
17,751,469 |
06/01/1006/30/10 |
|
256,600 |
|
10.4890 |
|
256,600 |
|
|
15,021,111 |
|
|
|
|
|
|
|
|
|
|
Total |
|
1,286,600 |
|
11.1481 |
|
1,286,600 |
|
$ |
15,021,111 |
|
|
|
|
|
|
|
|
|
|
On December 23, 2009, the Fund announced a stock repurchase
program effective for the duration of 2009 and 2010. Under the program, the Fund is authorized to make open-market repurchases of its common stock of up to $30 million. The Fund expects to repurchase its common stock when the discount to net asset
value of the trading price of its common stock on NYSE is greater than 5% subject to various factors, including the limitations imposed by the federal securities laws governing the repurchase of an issuers stock by the issuer and the ability
of the Advisor to raise cash to repurchase shares of the Funds common stock in a tax-efficient manner.
Item 10. |
Submission of Matters to a Vote of Security Holders. |
No material changes to procedures.
Item 11. |
Controls and Procedures. |
(a)The
registrants principal executive officer and principal financial officer have concluded, based on their evaluation of the registrants disclosure controls and procedures as conducted within 90 days of the filing date of this report, that
these disclosure controls and procedures are adequately designed and are operating effectively to ensure that information required to be disclosed by the registrant on Form N-CSR is recorded, processed, summarized and reported within the required
time periods specified in the Securities and Exchange Commissions rules and forms.
(b)There were no changes to the registrants
internal control over financial reporting (as defined in Rule 30a-3(d) under the Act (17 CFR 270.30a-3(d))) that occurred during the second fiscal quarter of the period covered by this report that have materially affected or are reasonably
likely to materially affect, the registrants internal control over financial reporting.
(a)(1) Not applicable.
(a)(2) Certifications pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (Exhibit filed herewith).
(a)(3) Not applicable.
(b) Certifications pursuant to Rule 30a-2(b) under the Investment Company Act of 1940 (Exhibit filed herewith).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the Registrant has duly caused this report to
be signed on its behalf by the undersigned, thereunto duly authorized.
Registrant The Swiss
Helvetia Fund, Inc.
|
|
|
|
|
By (Signature and Title)* |
|
/s/ Rudolf Millisits |
|
|
|
|
Rudolf Millisits |
|
|
|
|
Chief Executive Officer |
|
|
Date 8/18/10
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the
following persons on behalf of the Registrant and in the capacities and on the dates indicated.
|
|
|
|
|
By (Signature and Title)* |
|
/s/ Rudolf Millisits |
|
|
|
|
Rudolf Millisits |
|
|
|
|
Chief Executive Officer |
|
|
Date 8/18/10
|
|
|
|
|
By (Signature and Title)* |
|
/s/ Rudolf Millisits |
|
|
|
|
Rudolf Millisits |
|
|
|
|
Chief Financial Officer |
|
|
Date 8/18/10